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Abstract N6-methyladenosine (m6A) is the most abundant internal RNA modification of cellular
mRNAs. m6A is recognised by YTH domain-containing proteins, which selectively bind to m6A-
decorated RNAs regulating their turnover and translation. Using an m6A-modified hairpin present
in the Kaposi’s sarcoma associated herpesvirus (KSHV) ORF50 RNA, we identified seven members
from the ‘Royal family’ as putative m6A readers, including SND1. RIP-seq and eCLIP analysis
characterised the SND1 binding profile transcriptome-wide, revealing SND1 as an m6A reader. We
further demonstrate that the m6A modification of the ORF50 RNA is critical for SND1 binding,
which in turn stabilises the ORF50 transcript. Importantly, SND1 depletion leads to inhibition of
KSHV early gene expression showing that SND1 is essential for KSHV lytic replication. This work
demonstrates that members of the ‘Royal family’ have m6A-reading ability, greatly increasing their
epigenetic functions beyond protein methylation.
DOI: https://doi.org/10.7554/eLife.47261.001
Introduction
N6-methyladenosine (m6A) is the most prevalent internal modification of eukaryotic messenger
RNAs (mRNAs). Despite the identification of this modification over four decades ago, only recently
have major breakthroughs in our understanding of this modification been made due to the develop-
ment of m6A-seq, which allows immunoprecipitation of fragmented m6A-modified RNAs followed by
next-generation sequencing (NGS) analysis. m6A-seq and subsequent enhanced versions of the tech-
nique led to transcriptome-wide maps of cellular m6A modification (Dominissini et al., 2012;
Meyer et al., 2012; Patil et al., 2016). m6A writers have also been identified, a catalytically active
methyl-transferase, METTL3 (Wang et al., 2016), together with adapter components, catalyses m6A
addition onto specific RNA sequences containing the DRm6ACH motif, where D = A, G or U; R = A
or G; H = A, C or U. The RNA demethylases FTO (Jia et al., 2011) and ALKBH5 (Zheng et al., 2013)
can erase m6A marks offering a dynamic regulation of m6A status in RNA. Importantly, a family of
effector m6A readers have also been identified comprising five YT521-B homology (YTH) domain-
containing proteins. YTH readers directly bind m6A in target RNAs through an aromatic cage
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(Liao et al., 2018), directing their targets towards different biological fates. YTHDF2 recruits the
CCR4-NOT deadenylase complex and promotes degradation of m6A-containing RNAs (Du et al.,
2016; Wang et al., 2014) while YTHDF1, YTHDF3 and YTHDC2 stimulate mRNA translation of their
targets (Wang et al., 2015; Shi et al., 2017; Hsu et al., 2017) and YTHDC1 regulates mRNA splic-
ing (Xiao et al., 2016). Whether other proteins can directly recognise m6A has remained a question
to date. Other RNA-binding proteins can read m6A indirectly, in a so-called ‘m6A switch’ mechanism,
in which m6A destabilises the local RNA structure in hairpins allowing recruitment of either hnRNPC
to U-tracts (Liu et al., 2015) or hnRNPG to a purine-rich motif (Liu et al., 2017), both readers then
regulate alternative splicing. Recently, IGF2BP proteins were reported to enhance mRNA stability
and translation of m6A-containing RNAs and proposed to be a novel class of m6A readers
(Huang et al., 2018).
Due to recent transcriptome-wide m6A mapping of multiple viruses (Kennedy et al., 2016;
Lichinchi et al., 2016a; Tirumuru et al., 2016; Gokhale et al., 2016; Lichinchi et al., 2016b;
Courtney et al., 2017; Tsai et al., 2018; Hesser et al., 2018; Tan et al., 2018), it is becoming evi-
dent that there is an interplay between m6A-decorated viral RNA and cellular m6A machinery, result-
ing in modulation of viral replication output.
Kaposi’s sarcoma-associated herpesvirus (KSHV) is a DNA virus responsible for several Acquired
Immuno Deficiency Syndrome-associated aggressive malignancies (Baquero-Pe´rez and Whitehouse,
2015; Schumann et al., 2017). KSHV has a biphasic life cycle, with a latent phase and a productive
lytic phase. During latency, the KSHV episome is dormant in the nucleus of endothelial progenitor
cells and B-lymphocytes (Giffin and Damania, 2014), with few viral latent genes expressed. Under
various stimuli, the KSHV episome can be reactivated into lytic replication, leading to the ordered
expression of more than 80 viral proteins. The replication and transcription activator (RTA) viral pro-
tein, which is encoded from open reading frame 50 (ORF50), is the first lytic protein produced and is
essential for the latent-lytic switch (Guito and Lukac, 2012).
Here we accurately decipher the KSHV m6A epitranscriptome using a novel m6A peak-calling
algorithm and characterise m6A readers that specifically interact with KSHV m6A-modified RNA
eLife digest When a cell needs to make a protein, it reads from the master copy of the gene in
the DNA and prints out temporary duplicates called mRNA. These duplicates then act as templates
for protein production. Both DNA and mRNA can be further modified by adding on chemical tags
that recruit specific proteins. While chemical modifications in DNA are known to control the activity
of genes, their role in mRNA is only just being uncovered.
One of the most common chemical modifications in mRNA is the addition of a methyl group
called m6A. This methyl group has also been found in the mRNA of certain viruses, including the
Kaposi’s sarcoma-associated herpesvirus (KSHV) which causes cancer. Recent work has shown that a
family of proteins, known as the YTH family, can recognise and bind to this specific methyl group
and regulate the rate at which mRNA degrades. To investigate whether other proteins can
recognise m6A, Baquero-Perez et al. mapped the m6A residues of mRNAs encoded by KSHV genes
and looked at which proteins the methyl mark interacts with.
The experiments revealed that a family of proteins – nicknamed the ‘Royal family’ – that
recognise methyl groups in proteins, can also bind to mRNA that contains m6A. Baquero-Perez et al.
showed that a member of this family, SND1, can read the m6A methyl mark on mRNAs from both
the virus and the host cell. Further experiments showed that SND1 binds to and stabilises a viral
mRNA which provides the template for a protein that the virus needs to replicate. When SND1 was
removed from human immune cells infected with KSHV, this caused the virus to replicate less
efficiently.
The discovery that the Royal family of proteins can recognise methylated mRNA as well as
methylated proteins suggests that there may be a common feature that allows proteins to read
methylation. Understanding the shape of this feature could lead to new treatments that block
viruses from making the proteins they need to replicate.
DOI: https://doi.org/10.7554/eLife.47261.002
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sequences found in ORF50 and ORF37. Through the use of RNA affinity, in addition to YTH readers,
eight members from the Tudor domain ‘Royal family’, including SND1 (Staphylococcal nuclease
domain-containing protein 1), were specifically enriched in m6A-modified KSHV sequences. The
‘Royal family’ is a well-characterised family that reads methylated residues in histones through the
use of an aromatic cage (Chen et al., 2011) which is structurally similar to the one found in YTH
readers (Luo and Tong, 2014). Electromobility shift assays (EMSAs) demonstrate the ability of spe-
cific Royal domains to selectively bind m6A-modified RNA. As these domains do not bind all m6A-
modified RNA sequences it suggests this binding may occur in a RNA secondary structure/
sequence-dependent manner. We further developed a modified RIP-seq technique, which signifi-
cantly improves the resolution of standard RIP, accompanied by a unique bioinformatic analysis to
characterise for the first time the transcriptome-wide binding profile of SND1 to cellular and KSHV
mRNAs, revealing SND1 as a bona fide RNA-binding protein that targets m6A-modified RNAs in
KSHV-infected cells, including the extensively m6A-modified ORF50 RNA. SND1 eCLIP (enhanced
crosslinking immunoprecipitation) analysis using publically available datasets deposited in the ENCy-
clopedia Of DNA Elements (ENCODE) further confirmed that SND1 has a binding profile similar to
other m6A reader proteins. Importantly, depletion of SND1 in KSHV-infected cells significantly
reduced the stability of unspliced ORF50 RNA and led to markedly reduced levels of RTA protein
together with a global impairment of KSHV lytic replication. Furthermore, we show that m6A-modifi-
cation in ORF50 RNA regulates SND1 binding to this RNA, particularly to the unspliced form. These
data identify SND1 as an essential m6A reader for KSHV lytic replication and implicate the ‘Royal
family’ as a family which comprises m6A readers. This, considerably expands the landscape of m6A
readers and the epigenetic functions of Royal members beyond protein methylation.
Results
The KSHV transcriptome is extensively m6A-methylated in a cell type-
specific manner
We have previously developed dedicated software (m6aViewer) which implements a novel m6A
peak-calling algorithm that identifies high-confidence methylated residues with more precision than
previously described approaches (Antanaviciute et al., 2017). Utilising this software we mapped
m6A modifications in the KSHV transcriptome by performing m6A-seq in TREx BCBL1-Rta cells, a
BCBL1-based, primary effusion lymphoma B-cell line containing latent KSHV episomes capable of
doxycycline-inducible reactivation of lytic replication. We carried out m6A-seq in latent cells and cells
undergoing lytic replication for 8 hr and 20 hr post-induction in two biological replicates. In latent
cells, we consistently observed m6A peaks in six viral RNAs, including ORF72 and ORF73. At 8 hr
post-reactivation, 33 m6A peaks were identified in 21 KSHV ORFs in both biological replicates (Fig-
ure 1—figure supplement 1a). At 20 hr post-reactivation, 75 m6A peaks were mapped in 42 KSHV
ORFs (Figure 1a). The positions of these m6A peaks were highly reproducible across the different
time points and replicates (Figure 1—figure supplement 1b). 12 viral m6A peaks were further vali-
dated by two-step quantitative reverse transcription PCR (qRT-PCR) (Figure 1—figure supplement
2). m6A peaks in cellular RNAs were also consistently called, with 18,946 m6A peaks common to
both replicates in latent cells and 18,935 and 13,926 m6A peaks in cells reactivated for 8 hr and 20
hr, respectively (Figure 1b, Supplementary file 4). Cellular m6A peaks remained mostly unchanged
between latent and 8 hr of lytic replication. Lower detection of m6A peaks at 20 hr post-reactivation
was observed in part due to KSHV-mediated host cell shut-off (Conrad, 2009) (Figure 1c). However,
the majority of uniquely identified m6A peaks at this time point were found in RNAs whose expres-
sion was increased during lytic replication (Figure 1c). Cellular m6A peaks were enriched in the cod-
ing region (CDS) and 3’ untranslated region (UTR) throughout KSHV infection (Figure 1d). In viral
mRNAs, the majority of m6A peaks were located in the CDS (Figure 1e). We also confirmed the
DRm6ACH motif both in cellular and viral mRNAs (Figure 1f and g, respectively). Approximately
60% of viral m6A peaks contained the GGm6AC[G/U] motif, a significant over-representation of the
motif when compared to the expected DRm6ACH frequency.
A further comparison using our dedicated software was performed between our m6A-seq data-
sets and previously published m6A-seq studies carried out in TREx BCBL1-Rta cells (Tan et al., 2018)
and in a renal carcinoma cell line infected by recombinant KSHV BAC16 (iSLK cells) (Hesser et al.,
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Figure 1. The KSHV transcriptome is extensively m6A-modified. (a) KSHV epitranscriptome map in TREx BCBL1-Rta cells at 20 hr post-lytic reactivation.
m6A-IP reads and input reads are shown. m6A peaks identified by m6AViewer software with associated p-values are indicated. (b) Number of cellular
m6A peaks consistently called by m6AViewer software in two biological replicates throughout KSHV infection. (a,b) To define significantly enriched m6A
peaks in both viral and cellular RNAs, a minimum fold change of m6A-IP reads over input reads of  1.5 and a FDR < 5% was required in both
Figure 1 continued on next page
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2018; Tan et al., 2018). All raw sequencing data were subjected to quality control and processing
as described in methods and m6A peaks were identified with m6aViewer. Peaks were filtered to
keep only those with a minimum of 20 mean reads, 1% FDR (benjamini-hochberg) and an enrichment
of 4-fold m6A-IP/input. After applying these cut-offs, our TREx BCBL1-Rta cells datasets contained
twice as many m6A peaks as compared to the Tan dataset in the same cell line. ~17,000 and~10,000
cellular m6A peaks were identified in our dataset during latency and lytic replication, respectively,
while the Tan dataset yielded ~9,000 m6A peaks during latency and ~4,500 m6A peaks during lytic
replication (Figure 2a). The most cellular m6A peaks were identified in the Hesser datasets in iSLK
cells with ~25,000 m6A peaks. A direct one-to-one reciprocal overlap comparison between each of
our m6A peaks and those found in the other datasets was not possible, mostly due to vastly different
peak widths (with the other datasets having narrower peaks and containing short read length cou-
pled to single end data). In such situations, many peaks cannot be mapped one-to-one, with multiple
peaks often overlapping a single one when comparing datasets, which leads to overlap quantifica-
tions that are not easily interpretable. Therefore, we compared the overlap of m6A-modified tran-
scripts identified between all three studies. In TREx BCBL1-Rta cells, 72% of our 5,830 m6A-modified
transcripts in latent cells were also present in the same cell line during latency in the Tan dataset,
while 52% of our 4,059 m6A-modified transcripts in lytic cells were common to the lytic Tan dataset
(Figure 2b).~80% of m6A-modified transcripts in our TREx BCBL1-Rta dataset were also identified in
the Hesser dataset which mapped m6A in iSLK cells (Figure 2b). This analysis shows a high reproduc-
ibility identifying m6A-modified transcripts in KSHV-infected cell lines by three different groups.
Regarding viral m6A peaks, again, after applying the same data processing and cut-offs, we iden-
tified almost twice as many m6A peaks during lytic replication than the Tan dataset (Figure 2a). We
then compared the m6A-IP coverage maps of the KSHV transcriptome in lytic TREx BCBL1-Rta cell
lines, overall, viral m6A peaks were strikingly similar in both studies (Figure 2c). Of note, m6A peaks
in ORF50 RNA were consistently mapped in similar regions in both iSLK and TREx BCBL1-Rta cell
lines (Figure 2—figure supplement 1), with the highest similarity found between TREx BCBL1-Rta
cell lines. Although, in particular instances, m6A peaks differed between studies, for example ORF56
and ORF64 had a distinct m6A peak in this study but not in Tan et al. (Figure 2c and d, purple
boxes), while K12 was m6A-modified in Tan et al. but not in our study (Figure 2c and d, green box).
Intriguingly, when we compared the m6A-IP coverage maps between our lytic TREx BCBL1-Rta cells
and lytic iSLK cells from Tan et al., although clear common peaks were present, these maps differed
more than the TREx BCBL1-Rta cells (Figure 2c and d, blue lines) suggesting that the KSHV tran-
scriptome may be differentially modified depending on the cell type, suggesting potential epitran-
scriptomic remodelling of silencing and activating m6A motifs may take place differently between
cell types (Hesser et al., 2018; Tan et al., 2018).
Figure 1 continued
biological replicates. Peaks positions were considered overlapping between replicates if the calls were within 100 nucleotides between corresponding
positions. (c) Kernel density estimate (KDE) on the RNAs coding for the 10,190 m6A peaks present in latent but not 20 hr reactivated cells (left graph)
and on the RNAs coding for the 5,170 m6A peaks present at 20 hr reactivation but not in latent cells (right graph). (d) Distribution of m6A peaks in five
topological regions of cellular RNAs during latent and lytic KSHV replication. UTR, untranslated region. CDS, coding region. (e) Distribution of m6A
peaks in four topological regions of viral RNAs during latent and lytic KSHV replication. UTR, untranslated region. CDS, coding region. (f) Most
significantly enriched DRm6ACH consensus identified in m6A peaks present in four topological regions of cellular transcripts. MEME software was used
for motif analysis. (g) Most significantly enriched DRm6ACH motif found in viral transcripts. MEME software was used for motif analysis. (h) RNA affinity
baits were centred on the closest GGACU motif to the second m6A peak of open reading frame (ORF37) and the first and fourth m6A peaks of the
second exon of ORF50 transcript (blue triangles). m6A-IP reads and input reads for ORF37 and ORF50 transcript from two biological replicates at 20 hr
post-viral reactivation are shown.
DOI: https://doi.org/10.7554/eLife.47261.003
The following figure supplements are available for figure 1:
Figure supplement 1. The KSHV transcriptome is differentially m6A-modified during the course of reactivation.
DOI: https://doi.org/10.7554/eLife.47261.004
Figure supplement 2. Validation of m6A peaks.
DOI: https://doi.org/10.7554/eLife.47261.005
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Figure 2. Comparison of epitranscriptomic maps in different KSHV-infected cell lines (a, b) Fastq files were downloaded from SRA (GEO accessions:
GSE93676 and GSE104621) using sratoolkit. Raw sequencing data were subjected to quality control and processing as described in methods. Reads
were aligned to a combined human hg38 and KSHV genome reference. m6A peaks were identified with m6aViewer version 1.6.1. Peaks were filtered to
keep only those with a minimum of 20 mean reads, 1% FDR (benjamini-hochberg) and an enrichment of 4-fold m6A-IP/input. Overlapping m6A peaks
between replicates were collapsed using GenomicRanges R package and only peaks detected across all replicates were kept for further comparisons.
(b) Total number of overlapping m6A-modified transcripts identified between replicates are displayed for each dataset and time point in the grey
boxes. The percentage of the total m6A-modified transcripts identified in our dataset that overlap with previously published studies in TREx BCBL1-Rta
Figure 2 continued on next page
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RNA affinity identifies putative m6A readers which belong to the Tudor
domain ‘Royal family’
We were intrigued to determine whether any m6A readers uniquely interact with methylated viral
mRNAs. Of particular interest were the m6A peaks found in the second exon of ORF50 RNA, as this
RNA encodes the latent to lytic switch RTA protein. To this end, RNA affinity coupled to mass spec-
trometry analysis was performed. Viral RNA baits were centred on the closest GGACU motif to the
m6A peak positions of the largest peak of ORF37 and the first and fourth m6A peaks of the second
exon of ORF50 (Figure 1h) (hereafter referred to as ORF37, ORF50-1 and ORF50-4 baits respec-
tively). See Figure 3—figure supplement 1 for m6A peak positions from all m6A-seq time points.
Mass spectrometry analysis revealed that all three m6A baits enriched for YTH readers (Figure 3a).
An intriguing observation was that of the three viral baits, exclusively the methylated ORF50-1 (m6A-
ORF50-1) distinctly enriched SND1, a Tudor domain-containing protein. SND1 was in the top thir-
teen enriched protein hits, together with YTHDF1, YTHDF2 and YTHDF3. Further binding validation
of YTHDF1 and SND1 in RNA affinity experiments demonstrated that YTHDF1 was greatly enriched
in all three methylated baits while SND1 showed a modest but clear enrichment exclusively in m6A-
ORF50-1 bait (Figure 3—figure supplement 2). SND1 binds symmetrically dimethylated arginines
(sDMA) via its Tudor domain (Liu et al., 2010), thus it harbours the ability to selectively recognise
methyl groups. In addition to SND1, m6A-ORF50-1 bait also prominently pulled down three spliceo-
somal proteins known to interact with the Tudor domain of SND1, snRNP200, snRNP116 and PRPF8
(Yang et al., 2007). These proteins were within the top fifteen enriched protein hits. Multiple pro-
teins related to RNA processing were also enriched in this bait (Supplementary file 1). SND1
belongs to the Tudor domain ‘Royal family’, comprising five subfamilies: Tudor, plant agenet,
chromo, PWWP and MBT (Maurer-Stroh et al., 2003). Members from each subfamily share a struc-
turally related b-barrel that harbours an aromatic cage implicated in binding methylated arginines
and lysines (Chen et al., 2011). Intriguingly, the aromatic cage used for m6A recognition by YTH
readers is structurally similar to the one present in the ‘Royal family’ (Luo and Tong, 2014; Li et al.,
2014; Xu et al., 2015; Xu et al., 2014). Thus, further scrutiny for Royal members was carried out in
the mass spectrometry data. Strikingly, several Royal members were also enriched in methylated
viral baits. All three plant agenet members, which were recently identified as RNA sequence-depen-
dent m6A readers (Edupuganti et al., 2017; Arguello et al., 2017), were exclusively bound to m6A-
ORF50-1 bait (Figure 3a). Three PWWP domain-containing proteins were also enriched in m6A-
ORF50-1 bait while m6A-ORF37 bait retrieved the chromo protein CBX3 (Figure 3a). These results
suggest that Royal domains may be capable of reading methyl-decorations not only in proteins but
also in RNA. None of the indirect m6A readers, hnRNPA2B1, hnRNPC or hnRNPG, or IGF2BP pro-
teins were enriched in any of the baits (Supplementary file 2). Eight proteins with methyl-transferase
activity were also recruited to methylated baits (Supplementary file 2), of these, METTL16 is the
second m6A methyltransferase identified to date (Pendleton et al., 2017), which methylates struc-
tured RNAs where the adenosine is present in a bulge in the nonamer sequence UACAGAGAA,
where A is modified (Mendel et al., 2018). The remaining identified proteins may play a previously
uncharacterised role in the m6A RNA metabolism. Taken together, these results identify several
members from the ‘Royal family’ as putative m6A readers.
Figure 2 continued
and iSLK cells (Hesser et al., 2018; Tan et al., 2018) is shown, with 1 being 100%. (c) Comparison of the lytic epitranscriptomic map from our study
and the one performed by Tan et al., both carried out in TREx BCBL1-Rta. Circos plot of m6A-IP read coverage across the viral episome is shown for
both studies. Coverage tracks were scaled to account for differences in library sizes. KSHV gene positions are indicated by the central track. Some
differences in the identified m6A peaks between the two datasets are highlighted. (d) As described in c, but comparing Baquero et al. lytic TREx
BCBL1-Rta cells with lytic iSLK cells from Tan et al.
DOI: https://doi.org/10.7554/eLife.47261.006
The following figure supplement is available for figure 2:
Figure supplement 1. Viral ORF50 RNA is consistently detected as m6A-modified in different m6A-seq datasets.
DOI: https://doi.org/10.7554/eLife.47261.007
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Figure 3. LC-MS/MS identifies members from the ‘Royal family’ as putative m6A readers. (a) Mass spectrometry results of RNA affinity pull-downs using
m6A-modified and unmodified (control) biotinylated viral RNA baits. A single RNA affinity biological replicate for each RNA bait was carried out.
Statistical significance of enrichment was not determined, instead, all proteins identified for a given methylated and control bait were sorted by total
number of peptide spectrum matches (PSM’s) for the m6A bait. Proteins were then considered as enriched in methylated baits if the number of PSM’s
Figure 3 continued on next page
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Royal domains display selectivity for specific m6A-modified RNA
hairpins
We next determined whether the Royal domains from the Royal members enriched in methylated
viral RNAs display affinity for m6A-modified RNA in the absence of any other protein interaction.
The complete Royal Tudor domain of SND1 (residues 650–910) is required for sDMA-binding
(Liu et al., 2010), consequently, a GST-recombinant protein containing these residues (548-910),
referred here as SND1-C-terminus, was used in native electromobility shift assays (EMSAs). Notably,
SND1-C-terminus shifted m6A-ORF50-1 bait in contrast to the control bait (Figure 3b). Neither
ORF50-4 nor ORF37 methylated baits were selectively bound by SND1-C-terminus (Figure 3c and d,
respectively). Note that the membranes had to be overexposed to obtain a good shift signal due to
the small amount of shifted RNA in comparison with the free bait, consistent with the modest enrich-
ment of SND1 in m6A-ORF50-1 bait (Figure 3—figure supplement 2). Similarly, a weak shift has
also been previously observed in EMSAs for FMRP protein (Edens et al., 2019) and IGF2BP proteins
(Huang et al., 2018). RNA secondary structure prediction of all baits indicates that they form
strongly base-paired hairpins with an apical loop in which m6A is exposed and an additional large
unpaired bulge; however, ORF50-4 and ORF37 feature this unpaired bulge in the middle of their
stem (Figure 3—figure supplement 3). This may imply that SND1 cannot bind when the unpaired
bulge is present at this position irrespective of m6A. In contrast, the beginning of the stem of
ORF50-1 shows weak base-pairing with four unpaired bases (Figure 3—figure supplement 3, black
box) that may allow opening of the hairpin and selective SND1-binding when m6A is present. Curi-
ously, when running m6A-ORF50-1 bait on its own (without any protein), two distinct bands were
visualised, one lower band which migrated at the same speed of A-ORF50-1 bait and another higher
band migrating slower (Figure 3—figure supplement 4). Electrospray ionisation (ESI) of the ORF50-
1 baits showed that there were no truncated forms and that the correct molecular weight of a methyl
group had been added (15 daltons), demonstrating the purity of the baits (Figure 3—figure supple-
ment 4). As m6A can destabilise local RNA structure in hairpins (Liu et al., 2015), it seems plausible
that m6A addition to ORF50-1 destabilises the hairpin which then migrates slower compared with
the non-methylated bait. To test this hypothesis, a cropped version of ORF50-1 bait (cORF50-1) with
strong base-pairing throughout the stem (Figure 3—figure supplement 3) was tested in EMSAs.
Remarkably, SND1-C-terminus did not shift this bait (Figure 3e), highlighting that structural features
of the RNA ligand are critical for SND1-binding and that the beginning of the m6A-ORF50-1 hairpin
Figure 3 continued
assigned to the protein was at least double in the methylated bait compared with the control bait. In this table, the number of unique peptides
assigned to each protein is shown for each bait for clarity. (b–f) EMSAs were carried out using recombinant SND1-C-terminus protein (residues 548–910)
and biotinylated viral RNA baits. A cropped version of ORF50-1 bait (cORF50-1) and a stable version of ORF50-1 bait (named sORF50-1) in which the
beginning of the stem is made to have strong base pairing was also tested. Representative EMSAs from six and two independent protein purifications
for b and c-f, respectively.
DOI: https://doi.org/10.7554/eLife.47261.008
The following figure supplements are available for figure 3:
Figure supplement 1. m6A peak positions from all m6A-seq biological replicates studied.
DOI: https://doi.org/10.7554/eLife.47261.009
Figure supplement 2. Validation of RNA affinity pull-downs.
DOI: https://doi.org/10.7554/eLife.47261.010
Figure supplement 3. RNA secondary structure prediction of viral RNA baits.
DOI: https://doi.org/10.7554/eLife.47261.011
Figure supplement 4. A fraction of free m6A-ORF50-1 bait migrates slower than A-ORF50-1 bait.
DOI: https://doi.org/10.7554/eLife.47261.012
Figure supplement 5. Representative coomassie-stained SDS-PAGE gels for all recombinant proteins used.
DOI: https://doi.org/10.7554/eLife.47261.013
Figure supplement 6. Recombinant proteins containing the PWWP domain of PSIP1 and the plant agenet domain of FXR1 selectively bind m6A-
modified hairpins.
DOI: https://doi.org/10.7554/eLife.47261.014
Figure supplement 7. Neither CBX3 chromodomain nor GST protein show selectively for binding m6A-modified RNA.
DOI: https://doi.org/10.7554/eLife.47261.015
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(Figure 3—figure supplement 3, boxed region) may be required for an interaction with SND1. We
further mutated seven nucleotides to make this region very structured and stable, as demonstrated
by the increase in free energy of this stable hairpin (sORF50-1). No specific selectivity for m6A-
sORF50-1 by SND1-C-terminus was seen (Figure 3f), indicating that destabilisation of this region is
required for SND1 binding. Shorter exposure of the free m6A-sORF50-1 bait did not reveal two dis-
tinct bands as the ones present in m6A-ORF50-1 hairpin (Figure 3—figure supplement 4). To fur-
ther support the hypothesis that Royal domains harbour selectivity for m6A-modified RNA, GST-
recombinant proteins containing the Royal domains of FXR1, PSIP1 and CBX3 were tested in EMSAs.
Coomassie staining for all recombinant proteins can be seen in Figure 3—figure supplement 5. The
Royal domains of FXR1 and PSIP1 selectively shifted m6A-ORF50-1 bait, in contrast, none of the
other baits were bound (Figure 3—figure supplement 6a and b, respectively). The CBX3 chromo-
domain displayed a very faint shift for m6A-ORF50-1 bait, however this shift was not consistent
between protein preparations (Figure 3—figure supplement 7a) indicating that this domain either
may not be able to read m6A, or other protein partners could be required for its interaction with
m6A in vivo. Control glutathione S-transferase (GST), a protein with no RNA-binding properties, was
also tested in EMSA showing no selectivity for m6A-ORF50-1 bait (Figure 3—figure supplement
7b). EMSAs were also performed in the presence of excess herring sperm DNA as a source of non-
specific DNA. In the presence of sperm DNA no shift was detected and the free bait remained
uncomplexed (Figure 3—figure supplement 7c), suggesting that non-specific DNA prevents the
interaction between SND1 and m6A-ORF50-1 bait. This is not surprising as excess of DNA may
sequester SND1 which is a known DNA-binding transcription factor. Together, these results confirm
that Royal domains in the absence of any other protein interaction display selectivity for m6A-modi-
fied RNA, our data also suggests that this selectivity may occur in a RNA secondary structure-depen-
dent manner.
SND1 is an m6A reader in KSHV-infected cells
Next, we aimed to characterise the RNA-binding sites of endogenous SND1 transcriptome-wide dur-
ing KSHV infection by performing RIP-seq in two biological replicates. Latent and lytic TREx BCBL1-
Rta cells that had been reactivated for either 8 or 20 hr were used. We aimed to obtain the best pro-
tein binding site resolution by sonicating the majority of the total RNA to <200 bp (Figure 4—figure
supplement 1a and b). Unexpectedly, after construction of the cDNA library from the SND1-RNA
immunoprecipitated (RIP) samples, the majority of the fragments ranged from 150 to 1000 bp (Fig-
ure 4—figure supplement 1c). Thus, this technique has a binding site resolution of ~1 kB. A tran-
script-wide analysis enabled us to identify SND1 RNA targets, using a false discovery rate
(FDR) < 1% and a fold change of RIP reads over input reads >2, this analysis uncovered SND1 as a
bona fide RNA-binding protein, yielding 5061 target transcripts (Supplementary file 5). Of these,
3319 transcripts were mRNAs and 748 were long non-coding RNAs (lncRNAs). These target RNAs
were consistently bound by SND1 during latency and lytic KSHV replication (both at 8 and 20 hr).
Gene ontology (GO) analysis revealed that these transcripts code for proteins that are involved in
regulating GTPase activity, nervous system development and cell morphogenesis (Figure 4a). Next,
all highly expressed transcripts identified by RIP-seq (FDR < 1%) were divided into high-confidence
targets (those which had at least twice the normalised coverage in RIPs than input) and high-confi-
dence non-targets (those which had at least twice as much coverage in inputs than RIPs) and the pro-
portion of m6A-bearing RNAs in each group was determined. Strikingly, we observed that ~50% of
high-confidence targets and ~24% of high-confidence non-targets were m6A-modified RNAs
(Figure 4b), representing a marked enrichment of m6A-bearing RNAs in the target group. It is worth
noting that this transcript-wide analysis will not identify all SND1 targets, as when looking at the
SND1-binding profile at the transcript level, it was evident that some RNAs are bound by SND1 at a
specific region only (Figure 4c).
A positive correlation between the number of m6A peaks in a given transcript and the SND1-fold
enrichment was not found (Figure 4d). These results are not unexpected as they are in agreement
with the finding that SND1 does not bind m6A indiscriminately. We then mined previously processed
PAR-CLIP and m6A-seq data sets (Wang et al., 2014; Wang et al., 2015; Shi et al., 2017) from
HeLa cells and calculated the percentage of total RNA targets of YTH readers that contain m6A-
modified transcripts. ~ 65% of all RNA targets contained m6A-modified transcripts (Figure 4—figure
supplement 2). In addition, we compared the overlap of target genes containing or lacking m6A
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Figure 4. SND1 is a bona fide RNA-binding protein that targets transcripts bearing m6A modification. (a) Most significantly enriched GO terms
amongst the 5061 target RNAs (Ensembl transcripts) identified by RIP-seq which are consistently bound by SND1 at all time points (0 hr, 8 hr and 20 hr
post-reactivation) in TREx BCBL1-Rta cells. FDR, false discovery rate. (b) Consistently bound SND1 RNA targets throughout the course of KSHV infection
are enriched in m6A-modified RNAs, while non-targets are depleted. Target transcripts are defined by a fold change RIP/input > 2 while non-targets
Figure 4 continued on next page
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modification between SND1 and each heterologously expressed YTH reader. To our surprise,
despite comparing TREx BCBL1-Rta and HeLa cells, we found that ~50%,~32% and~37% of SND1
m6A-modified targets are common to YTHDF1, YTHDF2 and YTHDF3, respectively (Figure 4e).
When we compared the SND1 targets that lack m6A, only ~4%, ~1% and ~3% were shared with
YTHDF1, YTHDF2 and YTHDF3, respectively (Figure 4f). These results show that SND1 does not
merely co-precipitate with YTH readers and that it has a distinct RNA-binding profile.
To identify SND1 RNA targets that could be missed by transcript-wide analysis, a novel localised
enrichment analysis was developed similar to that used in ChIP-seq analysis (see
Materials and methods). In brief, both spliced transcripts and introns were segmented into a total
of ~750,000 transcriptomic regions based on changes in their fold change RIP/input (Figure 4g).
Applying a fold change >2 and >50 mean reads per region (FDR < 1%), 32,314 transcriptomic
regions were significantly bound by SND1. These regions encompassed 12,915 Ensembl transcripts
and after applying a cut-off of >2 fold m6A-IP/input enrichment and a minimum RIP read depth of
50,~40% of these transcripts were m6A-modified. 4872 of these total targets showed SND1-binding
throughout 5’UTR, CDS and 3’UTR (Figure 4h). We then focused on analysing SND1-enriched
intronic regions, as introns tend to be longer than spliced RNAs and RIP-seq has a low resolution,
we hypothesised that if SND1 is an m6A reader we might observe m6A peaks overlapping with
SND1-enriched regions in introns. Out of the total 32,314 SND1-enriched regions, 2563 regions
were found in introns. Of the latter, 516 intronic regions (20%), directly overlapped with m6A peaks
(Figure 5a and e). As a control for random overlap, 8,328 SND1-unbound intronic regions were
used, these were defined using a fold change RIP/input < 0.5 and >50 mean reads per region
(FDR < 1%). Of these, only ~1.3% (109) directly overlapped with m6A peaks (Figure 4e). SND1-
enriched regions overlapping m6A peaks in UTRs (Figure 5b) and lncRNAs (Figure 4—figure sup-
plement 3a) were also observed. In 5’UTRs and 3’UTRs we found ~40% overlap with m6A peaks in
SND1-enriched regions compared to only ~20% overlap of SND1-unbound regions (Figure 5e).
Next, we set out to investigate the SND1-enriched intronic regions for enriched motifs. Interest-
ingly, a U-tract was the most significant motif identified (Figure 4—figure supplement 3b). In addi-
tion, several GAC-containing motifs appeared as significantly enriched (Figure 4—figure
supplement 3c). When searching for motifs that were 30 nucleotides long in SND1-bound intronic
regions containing m6A peaks, a U-tract immediately followed by an m6A motif was identified (Fig-
ure 4—figure supplement 3d). In SND1-bound intronic regions that do not have m6A peaks, a
U-tract was also the most enriched motif. Notably, U-rich motifs found adjacent to m6A residues are
also targeted by RBM15/15B and hnRNPC (Patil et al., 2016; Liu et al., 2015).
Figure 4 continued
have a fold change input/RIP > 2. A false discovery rate (FDR) < 1% is applied to RIP-seq data. (c) Hierarchical clustering of fold change RIP/input for
SND1 targets. (d) No significant correlation between the number of m6A peaks in a given RNA and the binding of SND1 as determined by log2 fold
change RIP/input. Target transcripts with >300 mean reads of coverage per RNA were used for the analysis. Analysis using a lower expression cut-off
showed similar results. (e, f) High-confidence SND1-bound genes (summarised at HGNC gene symbol annotation level) were defined using a cut-off of
FDR < 1% and a fold change RIP/input > 2, while m6A peaks were detected using a FDR < 5% and > 1.5 fold m6A-IP reads over input reads. RNA
targets and m6A peaks for YTH readers were mined from publically available PAR-CLIP and m6A-seq datasets from HeLa cells. (e) Overlap of target
genes with m6A modifications between SND1 and heterologously expressed YTH reader proteins. (f) Overlap of target genes lacking m6A
modifications between SND1 and heterologously expressed YTH reader proteins. (g) For SND1 localised enrichment analysis, introns are collapsed and
exons spliced together into a single continuous RNA molecule. Spliced transcripts and introns are then segmented into transcriptomic regions based
on changes in their fold change RIP/input. (h) Venn diagram showing the overlap between SND1 enrichment in coding region (CDS) and untranslated
regions (UTRs) of SND1 target transcripts identified by localised enrichment analysis.
DOI: https://doi.org/10.7554/eLife.47261.016
The following figure supplements are available for figure 4:
Figure supplement 1. Long RNA fragments crosslinked to SND1 are enriched over shorter fragments during RIP.
DOI: https://doi.org/10.7554/eLife.47261.017
Figure supplement 2. 65 % of all RNA targets of YTH readers contain m6A-modified transcripts.
DOI: https://doi.org/10.7554/eLife.47261.018
Figure supplement 3. Bioinformatic analysis of SND1 RIP-seq data.
DOI: https://doi.org/10.7554/eLife.47261.019
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Figure 5. SND1 RNA-binding sites specifically overlap m6A peaks (a, b) Genome sequencing tracks from latent (0 hr) and lytic (8 hr and 20 hr post-
reactivation) TREx BCBL1-Rta cells depicting input (green) and RIP (blue) coverage. m6A-IP reads (red) are also shown. Blue boxes indicate exons while
blue lines represent introns. SND1 overlaps with m6A peaks are evident in introns (ARL17A) and 5’UTRs (ABCD1). Note that in ABCD1, SND1 binding
and m6A peaks are both reduced at 8 hr post-reactivation while at 20 hr post-reactivation methylation and SND1 binding signal are both lost with
decreasing expression in inputs. (c, d) Dynamic SND1 binding to m6A-modified regions in SND1 target transcripts during KSHV infection. Genome
Figure 5 continued on next page
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RIP-seq also enabled us to identify differential SND1-binding to target RNAs that correlated to
both differentially m6A-modified RNAs and the status of KSHV infection. During latency, one of the
introns in TPO transcript was not m6A-modified and failed to bind SND1. In contrast, at 8 hr and 20
hr post-reactivation, several adenosines in this intron are m6A-modified and SND1 binding ensues
(Figure 5c). The reverse scenario was also observed for example in the overlapping DUSP5P1-RHOU
transcripts, in which specific m6A peaks and SND1-enriched regions present at 0 hr and 8 hr post-
reactivation disappeared at 20 hr of lytic reactivation (Figure 5d). A list of these differential SND1-
binding events to target RNAs can be accessed in Supplementary file 6. Taken together, these
results demonstrate that SND1 targets m6A-modified regions in KSHV-infected cells at the transcrip-
tome level.
To further address the binding profile for SND1 we re-analysed multiple eCLIP datasets from the
ENCODE consortium for established m6A reader proteins and SND1 (Van Nostrand, 2017). Since
the eCLIP datasets were derived from HepG2 cells, we firstly assessed the overlap between the m6A
profile in latent TREx BCBL1-Rta cells and HepG2 cells using an existing m6A-seq dataset from
HepG2 cells (Huang et al., 2018) (Figure 6a). This revealed an extensive overlap of transcripts which
contain m6A sites in these two cells lines, with 77% of TREx BCBL1-Rta m6A-modified transcripts
being present in HepG2 cells. We then investigated the overlap between transcripts which are m6A-
modified and bound by SND1 from RIP-seq and eCLIP datasets (Figure 6b). This showed an overlap
of 1166 transcripts bound by SND1 of which 88% contained m6A sites. We next compared the
extent of overlap between m6A and eCLIP peaks on transcripts (Figure 6c). We found comparable
binding site overlap for SND1 and established readers with m6A peaks, whereas a control protein
(TIAL1) showed reduced overlap between m6A peaks and its binding sites. We investigated the rep-
ertoire of transcripts bound by SND1 and other reader proteins and found extensive binding to pro-
tein coding transcripts (Figure 6d). SND1 showed a similar distribution to m6A across transcripts
with a bias towards coding region binding in common with most other reader proteins, whereas the
control TIAL1 protein displayed a strong 3’ UTR bias (Figure 6e). We used HOMER to identify motifs
bound by SND1 and other established reader proteins using the ENCODE eCLIP datasets. This anal-
ysis, using peaks called from all transcripts, revealed a common sequence GGAC, the core of the
consensus motif surrounding m6A sites. For SND1, this motif is further enriched from the eight high-
est scoring motif, when performed on all eCLIP peaks (30,121 peaks), to the second highest scoring
motif, upon restricting the analysis to SND1 binding sites on exons which contain the m6A modifica-
tion (7965 peaks), of which 58% (4,637) directly overlap an m6A site (Figure 6f). Together, this analy-
sis reveals that SND1 recognises the consensus m6A motif in vivo and has a similar binding profile to
other established reader proteins.
Regarding KSHV viral mRNAs, we were able to confirm ORF50 RNA as a high-confidence SND1
target. As a comparison, a highly expressed viral lytic RNA, ORF57, did not reach the cut-off to be
considered a high-confidence target (Figure 4—figure supplement 3e). We additionally identified
33, 23 and 14 KSHV transcripts as high-confidence SND1 targets at 0 hr, 8 hr and 20 hr post-reacti-
vation, respectively (Figure 7a). Deep-sequencing coverage for high-confidence SND1 targets can
be seen in Figure 7—figure supplements 1 and 2. Validation of SND1-binding to the different
regions containing m6A peaks in the second exon and the intron of ORF50 RNA was performed by
RIP followed by RT-qPCR. A ~ 40 fold SND1 enrichment was detected in the second exon of ORF50
and a ~ 10 fold enrichment in the intron compared with the SND1 enrichment detected on the non-
target 18S rRNA (Figure 7b). We further tested by RIP the binding of endogenous FXR1, FXR2,
PSIP1, YTHDF1 and YTHDF3 to ORF50 RNA, while non-specific rabbit immunoglobulin (IgG) was
Figure 5 continued
tracks depicting sequencing read coverage from input (green) and RIP (blue) samples. m6A-IP reads (pink) are also shown. Note that in contrast to
ABCD1, RHOU/DUSP5P1 remain highly expressed even at 20 hr post-reactivation, suggesting the coupled loss of methylation/SND1-binding is
independent of the ability to detect these events due to loss of expression. (e) SND1 regions consistently enriched across the three time points studied
(0 hr, 8 hr and 20 hr) were defined by applying a fold change RIP/input >2 and>50 mean reads per region (FDR < 1%). Consistently SND1-unbound
regions throughout KSHV infection were defined using a fold change RIP/input <0.5 and>50 mean reads per region (FDR < 1%). For all m6A overlap
analysis, the cut-off for an m6A peak was defined as having 50 read paired at the tallest point in the m6A peak and a 2-fold enrichment of m6A-IP reads
over input reads using a FDR < 1%.
DOI: https://doi.org/10.7554/eLife.47261.020
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Figure 6. SND1 binds the consensus m6A motif. (a) Overlap of m6A-modified transcripts in the indicated cell lines. (b) Overlap between the indicated
eCLIP, RIP-seq and m6A-seq enriched transcripts. (c) Direct overlap of m6A-seq peaks and eCLIP binding sites for m6A reader proteins (FXR2, IGF2BP1,
IGF2BP3), SND1 and the control, TIAL1. (d) Distribution of binding sites for the indicated proteins across RNA biotypes. (e) Distribution of binding sites
across different transcript regions for the indicated proteins. (f) Motif analysis using HOMER and HepG2 eCLIP datasets as indicated. Top panel m6A-
Figure 6 continued on next page
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used as negative control antibody. The YTHDF1 RNA target SON (Wang et al., 2014) was used as a
binding control RNA for YTH readers. Both YTH readers and FXR2 bound ORF50 RNA, showing
a ~ 8 fold enrichment (Figure 7b) and ~15 fold enrichment was observed for FXR1. PSIP1 showed a
limited but consistent enrichment (~3 fold) above the negative control IgG. These results highlight
that all these Royal members can target ORF50 RNA, SND1 displaying the highest affinity.
SND1 stabilises ORF50 RNA and is essential for KSHV replication
Having established the SND1 RNA-binding topology, we further investigated the role of SND1 in
KSHV infection and its relationship with ORF50 RNA. Here, two TREx BCBL1-Rta cell lines with stable
shRNA knockdown of SND1 (SND1 KD1 and SND1 KD2) and a shRNA scramble cell line were gener-
ated. Surprisingly, following 24 hr of lytic replication there were no significant differences between
the scramble and the knockdown cell lines in the amount of KSHV lytic transcripts produced
(Figure 7c). In accordance with mRNA levels, RTA and ORF57 proteins were not reduced
(Figure 7d). Similarly, the early lytic protein ORF54 was not decreased (Figure 7d). These data were
also confirmed by RNA-seq performed in scramble and SND1 KD2 cells from two biological repli-
cates. Following 24 hr of lytic reactivation, expression of the KSHV transcriptome in SND1-depleted
cells was not significantly altered from scramble cells, with the exception of upregulation of ORF71
and ORF72 mRNAs (Figure 7e). qRT-PCR analysis confirmed a ~ 4 fold-induction of these transcripts
in SND1-depleted cells during the lytic cycle (data not shown). These results possibly suggest that
SND1 plays a role in maintaining low expression of these latent RNAs during lytic replication. Impor-
tantly, in the presence of overexpressed RTA protein, KSHV lytic replication is essentially unchanged
in SND1-depleted TREx BCBL1-Rta cells, thus these cells still fulfil all viral functions necessary for
triggering the lytic cascade.
TREx BCBL1-Rta cells are reactivated by expression of Myc-tagged RTA which is integrated in the
host genome in a spliced form and its expression is under the control of a doxycycline-inducible pro-
moter. In contrast, the parental BCBL1 cell line lacks Myc-tagged RTA and reactivation is achieved
by addition of the histone deacetylase inhibitor sodium butyrate (NaB), which leads to the expres-
sion of unspliced ORF50 RNA. This native RNA matures to the spliced form giving rise to RTA pro-
tein, which then transactivates the ORF50 promoter in a positive transcriptional feedback
mechanism (Guito and Lukac, 2012). However, as SND1 does not take part in the splicing of ORF50
RNA (Figure 7c), it therefore suggests a potential role in the stabilisation of ORF50 RNA, which
could be masked by constitutive overexpression of Myc-tagged RTA in TREx BCBL1-Rta cells. Thus,
the same lentiviral shRNAs targeting SND1 were used to knockdown SND1 in BCBL1 cells. Remark-
ably, both SND1 knockdown cell lines showed a dramatic decrease in viral RNAs, including ORF50
RNA (Figure 7f), and RTA, ORF57 and ORF54 protein levels (Figure 7g). These data were also con-
firmed by RNA-seq performed in scramble and SND1 KD2 BCBL1 cells from two biological repli-
cates. After 24 hr of lytic reactivation, 48 KSHV RNAs were significantly downregulated in SND1-
depleted cells compared with scramble cells (FDR < 5%), including ORF50 RNA (Figure 7h). These
results indicate that in the absence of SND1 there is a global impairment of lytic KSHV replication
downstream of RTA and uncover SND1 as an essential protein for lytic KSHV replication.
Although SND1 did not affect splicing of the ORF50 RNA, we assessed whether SND1 regulated
splicing events in cellular RNA processing, due to the previously reported role of SND1 in the regu-
lation of splicing (Jariwala et al., 2015). Thus we hypothesised that SND1 may play a role in splicing
through binding methylated intronic regions. Splicing analysis revealed multiple significant differen-
tial splicing events between scramble latent cells and scramble lytic TREx BCBL1-Rta cells, however,
there were no significant splicing differences between scramble and SND1-depleted cells, when ana-
lysing cellular or viral transcripts from either latent or lytic cells (Figure 8a). The same results were
also observed in BCBL1 cells (data not shown).
Figure 6 continued
seq derived motif in HepG2 cells (note that this is the highest scoring motif derived), central panels are consensus motifs found using all target
transcripts, bottom panel is the two most highly enriched SND1 motifs in the set of m6A-modified exons bound by SND1.
DOI: https://doi.org/10.7554/eLife.47261.021
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Figure 7. SND1 binds the essential ORF50 RNA in KSHV-infected cells and SND1 knockdown significantly impairs KSHV lytic replication. (a) RIP-seq
identifies KSHV mRNAs as high-confidence SND1 targets at 0 hr (left panel), 8 hr (middle panel) and 20 hr (right panel) post-reactivation. Red dashed
line indicates a cut-off of >2 fold change RIP/input. Red arrow points ORF50. Note that lytic genes are also detected in latent cells (0 hr) due to
spontaneous KSHV reactivation and the high sensitivity of deep-sequencing. As expected, significantly lower coverage for these lytic genes was
Figure 7 continued on next page
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As SND1 has previously been described as a transcriptional activator (Jariwala et al., 2015) we
determined whether it could associate with the ORF50 promoter by carrying out chromatin immuno-
precipitation (ChIP) with the ChIP-grade antibody we previously used for RIP-seq experiments. RNA
polymerase II (RNAPII) antibody (clone CTD4H8) and non-specific immunoglobulin (IgG) were used
respectively as positive and negative control antibodies. Whilst RNAPII was enriched at the GAPDH
promoter and multiple viral promoters including ORF50, there was no significant enrichment for
either SND1 or the non-specific IgG (Figure 7—figure supplement 3). Moreover, RNA-seq analysis
of TREX BCBL1-Rta-SND1 depleted cells showed no significantly downregulated viral gene expres-
sion (Figure 7e). Consequently, we conclude that SND1 does not participate in the activation of the
ORF50 promoter.
The strikingly different knockdown phenotype between TREX BCBL1-Rta and BCBL1 cells directly
points to a potential regulatory role of SND1 on the essential lytic ORF50 RNA, and suggests that
SND1 may stabilise the ORF50 RNA. To test this hypothesis without the possible interference of
NaB on ORF50 RNA decay, the decay of native (unspliced) ORF50 RNA was monitored in scramble
and SND1-depleted TREx BCBL1-Rta cells that had been reactivated into the lytic cycle for 24 hr
before addition of actinomycin D. Strikingly, native ORF50 RNA was significantly more unstable in
SND1-depleted cells (Figure 8b) with ~80% of ORF50 RNA remaining at 6 hr post-transcription inhi-
bition in scramble cells and ~50% in depleted cells. To further determine whether SND1 may also
play a role in regulating the stability of ORF71 and ORF72 RNAs during the KSHV lytic cycle, the
turnover of these transcripts together with other high confidence SND1 KSHV RNA targets was also
investigated. In contrast to ORF50 RNA, these transcripts decayed in a similar manner in scramble
and depleted cells (Figure 8b).
Figure 7 continued
detected during latency compared with lytic replication. (b) RIP for endogenous SND1, FXR1, FXR2, PSIP1, normal rabbit IgG, YTHDF1 and YTHDF3
followed by qRT-PCR detection. ORF50-1, ORF50-2, ORF50-3 and ORF50-4 indicate primers that generate an amplicon spanning the first, second, third
and fourth m6A peaks of the second exon of ORF50 RNA, respectively. ORF50-intron generates an amplicon spanning the m6A peak in the ORF50
intron. ORF50 negative primers were designed at the start of the second exon of ORF50 RNA. Fold enrichment is relative to the enrichment of the non-
target 18S rRNA. Values are averages, error bars present s.d. For SND1 RIPs, n = 4 independent RIPs, for FXR1, FXR2 and normal rabbit IgG n = 3
independent RIPs. For PSIP1 and YTH proteins, n = 2 independent RIPs. (c–h) Stable cell lines expressing scramble shRNA (scr. KD) or two independent
shRNAs targeting SND1 were generated using TREx BCBL1-Rta cells (c–e) or BCBL1 cells (f–h). (c) Cellular and viral RNA levels were measured by qRT-
PCR 24 hr post-reactivation. n = 3 independent viral reactivations. Values are averages, error bars present s.d. ***p<0.001 using an unpaired t-test.
ns = not significant. (d) Immunoblot analysis of protein lysates from latent or 24 hr reactivated cells. ORF57 antibody detects both full length ORF57
protein (black arrow) and the caspase-7-cleaved form (white arrow). For SND1 detection a rabbit polyclonal antibody was used. Western blots are
representative of two independent viral reactivations. (e) Volcano plot displaying viral expression of scramble KD and SND1 KD2 cells 24 hr post-
reactivation analysed by RNA-seq. The green arrow highlights the quadrant containing upregulated viral ORFs in depleted cells. The red arrow
highlights the quadrant containing downregulated ORFs in depleted cells. The red dashed line denotes the FDR < 1% cut-off. (f) Cellular and viral RNA
levels were measured by qRT-PCR 24 hr post-reactivation. n = 3 independent viral reactivations. Values are averages, error bars present s.d. **p<0.01,
***p<0.001 using an unpaired t-test. (g) Immunoblot analysis of protein lysates from latent or 24 hr reactivated cells. Western blots are representative of
two independent viral reactivations. (h) Volcano plot displaying viral expression of scramble KD and SND1 KD2 cells 24 hr post-reactivation analysed by
RNA-seq. The red and purple dashed lines denote the FDR < 1% and FDR < 5% cut-offs, respectively.
DOI: https://doi.org/10.7554/eLife.47261.022
The following source data and figure supplements are available for figure 7:
Source data 1. Source data for qRT-PCR experiments and uncropped western blots.
DOI: https://doi.org/10.7554/eLife.47261.028
Figure supplement 1. Sequencing coverage tracks for SND1 high-confidence viral RNA targets at 20 hr post-reactivation.
DOI: https://doi.org/10.7554/eLife.47261.023
Figure supplement 2. Sequencing coverage tracks for SND1 high-confidence viral RNA targets at 20 hr post-reactivation.
DOI: https://doi.org/10.7554/eLife.47261.024
Figure supplement 3. SND1 does not bind the KSHV ORF50 promoter.
DOI: https://doi.org/10.7554/eLife.47261.025
Figure supplement 4. m6A methylation has a pro-viral role in the KSHV lytic life cycle.
DOI: https://doi.org/10.7554/eLife.47261.026
Figure supplement 5. Depletion of YTH readers impairs KSHV lytic replication.
DOI: https://doi.org/10.7554/eLife.47261.027
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Figure 8. SND1 stabilises native ORF50 RNA and inhibition of m6A deposition on this RNA abolishes SND1 binding. (a) RNA-seq analysis reveals
significant alterations in splicing events between scramble latent and scramble lytic TREx BCBL1-Rta cells (left panel), whilst no significant changes in
splicing are observed between scramble and SND1-depleted cells during latency (middle panel) or 24 hr lytic replication (right panel). (b) TREx BCBL1-
Rta cells were reactivated for 24 hr into the lytic cycle and transcription was inhibited with the addition of actinomycin D (2.5 mg/ml). Transcripts of
Figure 8 continued on next page
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Removal of m6A in ORF50 RNA impairs SND1 binding to ORF50 RNA
Due to the broad and overlapping m6A-seq peaks across the ORF50 RNA and the high frequency of
DRm6ACH motifs throughout ORF50 RNA, we attempted to deplete global m6A levels in ORF50
RNA by stably depleting METTL3 in BCBL1 cells and assess its effect on lytic replication, however
limited depletion was achieved and no significant effect on KSHV lytic replication was observed
(data not shown). The same METTL3 knockdowns were repeated in BCBL1 cells but transiently. After
five days post-lentiviral transduction, cells were reactivated for 24 hr and viral and protein levels ana-
lysed. Here, one METTL3 knockdown cell line (METTL3 KD2) achieved a higher level of depletion of
METTL3 protein and viral transcript and protein levels were both significantly reduced compared
with the scramble cell line (Figure 7—figure supplement 4a and b). In contrast, a second cell line
(METTL3 KD1) showed no depletion of METTL3 protein and no significant differences in viral replica-
tion between these cells and the scramble were observed (Figure 7—figure supplement 4a and b).
In addition, we generated stable BCBL1 cell lines harbouring shRNA knockdown of either FTO,
YTHDF1 or YTHFD3. In contrast, despite consistently achieving ~75% depletion of YTHDF2 at the
mRNA level, following 12 days post-transduction these depleted cells would dramatically lose their
knockdown at the mRNA level, suggesting that YTHDF2 may be essential for BCBL1 cells, therefore
we performed transient transductions for YTHDF2. Following reactivation, FTO-depleted cells dis-
played increased viral mRNA and protein levels (Figure 7—figure supplement 4c and d), including
increased levels of ORF50 RNA and RTA protein. Depletion of YTHDF1 or YTHDF3 readers resulted
in decreased ORF50 RNA together with other lytic RNAs (Figure 7—figure supplement 5a-b and
e-f), particularly, in YTHDF1-depleted cells, which also showed a marked reduction of viral protein
levels. Depletion of YTHDF2 did not affect viral RNA levels, with the exception of PAN RNA, how-
ever a clear decrease in RTA protein and a slight reduction in ORF57 protein levels were evident
(Figure 7—figure supplement 5c and d). Taken together, these results indicate that m6A modifica-
tion has a pro-viral role in the KSHV lytic replication cycle, in agreement with previous studies per-
formed in the same cell line (Ye et al., 2017).
Next, we set out to determine whether the m6A status of ORF50 RNA regulates SND1 binding.
Firstly, single-point mutations were performed in the GGACU motifs present in ORF50 baits to eluci-
date whether the chosen motifs were m6A-modified in the context of the full length ORF50 RNA.
Wild type (WT) FLAG-ORF50 -containing both ORF50 exons and the intron- and mutant plasmids
were transfected into HEK-293 cells and m6A enrichment quantified by m6A-IP-qPCR (Figure 8c). In
transfected cells, ORF50 RNA was particularly m6A-modified in ORF50-1 and ORF50-4 regions, sug-
gesting cell type differences between TREx BCBL1-Rta and HEK-293 cells. Point mutation in the
motif contained in ORF50-1 bait, but not in ORF50-4 bait, significantly reduced m6A enrichment,
confirming that this site is m6A-modified. Next, the binding of SND1 to WT FLAG-ORF50 and to a
Figure 8 continued
interest were measured by qRT-PCR at 0 hr, 3 hr and 6 hr post-transcription inhibition (TI). Each viral gene was normalised against 18S rRNA. Values are
averages, error bars present s.d. n = 4 independent viral reactivations. (c) m6A-enrichment was determined by m6A-IP-qPCR. HEK 293 cells were
transfected for 24 hr with either wild type (WT) FLAG-ORF50 or a double mutant plasmid in which the GGACT motifs present in the ORF50-1 and
ORF50-4 baits were mutated to GGATT. When using DAA, 4 hr after transfection DAA was added at a concentration of 200 mM, and 24 hr post-
treatment cells were harvested. % of input was calculated similarly as to ChIP-qPCR analysis. Values are averages, error bars present s.d. *p<0.05,
**p<0.01, ***p<0.001 using an unpaired t-test. ns = not significant. For WT ORF50 n = 9 independent m6A-IPs [3 including 0.25% (v/v) DMSO-
treatment), for double mutant ORF50 n = 3, for DAA-treated cells n = 3. (d) HEK 293 cells were transfected for 24 hr with either wild type (WT) FLAG-
ORF50 or a single mutant plasmid in which the GGACT motif present in the ORF50-1 bait was mutated to GGATT. For DAA-treated cells, 4 hr after
transfection DAA was added at a concentration of 200 mM, and 24 hr post-treatment cells were harvested. SND1 enrichment was determined by SND1-
RIP-qPCR and is relative to the enrichment found in the non-target 18S rRNA. GAPDH RNA served as an additional non-target RNA. Values are
averages, error bars present s.d. For WT and mutant ORF50 n = 4 independent RIPs. For DAA-treated cells n = 3 independent RIPs. *p<0.05, **p<0.01
using an unpaired t-test.
DOI: https://doi.org/10.7554/eLife.47261.029
The following source data and figure supplement are available for figure 8:
Source data 1. Source data for qRT-PCR experiments.
DOI: https://doi.org/10.7554/eLife.47261.031
Figure supplement 1. DAA was not cytotoxic in HEK-293 cells.
DOI: https://doi.org/10.7554/eLife.47261.030
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FLAG-ORF50 plasmid with a point mutation in the motif contained in ORF50-1 bait was evaluated
by RIP. No significant decrease in SND1 binding was observed (Figure 8d), indicating that other
SND1 binding sites are necessary for ORF50 RNA-SND1 interaction.
We finally assessed the binding of SND1 to ORF50 RNA in the absence or presence of m6A modi-
fication. For this purpose, we made use of the drug 3-deazaadenosine (DAA), which inhibits m6A
deposition by reducing levels of the methyl donor S-adenosylmethionine (SAM). HEK-293 cells were
transfected with WT FLAG-ORF50 plasmid and 4 hr after transfection, control 0.25% (v/v) DMSO or
200 mM DAA was incubated for an additional 24 hr. Note that DAA did not result in cytotoxicity at
this concentration after 26 hr post-treatment (Figure 8—figure supplement 1). DAA effectively
reduced m6A enrichment in all m6A-modified regions of ORF50 RNA (Figure 8c) and led to a signifi-
cant decrease of SND1 binding across ORF50 RNA (Figure 8d). Interestingly, DAA completely abol-
ished SND1 binding to the native ORF50 transcript, indicating that m6A inhibition on ORF50 RNA
regulates SND1 binding to it, however the exact points of interaction between SND1 and ORF50
RNA remain to be elucidated at single nucleotide resolution.
In summary, these experiments propose a model where in the absence of SND1, unspliced
ORF50 RNA is more unstable resulting in reduced RTA protein levels which will further reduce acti-
vation of the RTA promoter in a negative feedback loop that culminates in lytic replication
impairment.
Discussion
SND1 is a multi-functional protein. It functions as a transcriptional co-activator of Epstein-Barr virus
nuclear protein 2, STAT5, STAT6 and c-Myb (Jariwala et al., 2015). Additionally, SND1 has multiple
roles modulating gene expression at a post-transcriptional level. SND1 is a component of the RISC
complex (Jariwala et al., 2015) and acts in the processing of specific miRNAs (Heinrich et al.,
2013). m6A promotes processing of primary miRNAs (pri-miRNAs) (Alarco´n et al., 2015), thus SND1
may also process m6A-modified pri-miRNAs, which could explain the SND1-binding in methylated
introns we observed. In agreement with our finding that SND1 stabilises ORF50 RNA, SND1 binds
to the 30UTR of angiotensin II type one receptor (AT1R) and stabilises this mRNA leading to elevated
protein AT1R levels (Jariwala et al., 2015). Intriguingly, AT1R mRNA contains a single m6A site
which is located in the 3’UTR region (Sun et al., 2016). Finally, SND1 also participates in RNA edit-
ing (Jariwala et al., 2015). Under stress conditions, in mammalian cells SND1 co-localises with G3BP
protein in stress granules (Gao et al., 2010) and stabilises AT1R and IGFBP2 mRNAs (Gao et al.,
2015). Similarly, in plants SND1 is essential for the stabilisation of a subset of stress-responsive
mRNAs (Frei dit Frey et al., 2010). It will be of interest to address to what extent SND1 regulates
the stability of its target RNAs. Curiously, the readers YTHDF1-3, FXR1, FXR2 and FMR1 have also
been identified in mammalian stress granule cores (Jain et al., 2016).
We performed RNA-lifetime profiling in scramble and SND1-depleted cells using latent and lytic
TREx BCBL1-Rta and BCBL1 cells; however the NGS data were extremely noisy and this precluded
us from identifying a consistent phenotype between replicates.
To date, very little research has been performed on deciphering the role of SND1 during viral
infections. SND1 binds the 3’UTRs of transmissible gastroenteritis coronavirus (TGEV) (Gala´n et al.,
2009) and dengue virus (DENV). Moreover, SND1 silencing reduced the levels of viral RNA and pro-
tein in DENV-infected cells (Lei et al., 2011). Intriguingly, the 3’UTR of DENV contains m6A sites
(Gokhale et al., 2016), thus it would be of considerable interest to examine whether this modifica-
tion enables SND1 recruitment to the 3’UTR to stabilise the RNA DENV genome.
Differences in the binding affinities for the different RNA baits used in this study between YTH
readers and the Royal members can be inferred from previous structural studies. Interestingly, in
SND1 (Chen et al., 2009a), plant agenet members (Adams-Cioaba et al., 2010), PSIP1, HDGFRP2
and MSH6 (Qin and Min, 2014), the aromatic pocket is hydrophobic and surrounded by both posi-
tive and negative residues thus, it seems plausible that binding only ensues when matching electro-
static interactions are achieved between the RNA sequence and the Royal domain, consequently,
methylated proteins would adopt a different orientation to interact with negatively charged residues
while m6A-decorated RNAs would interact with positively charged residues. This model would
explain the RNA structure dependency observed for these proteins in binding m6A-modified RNA.
In contrast, the aromatic cage of YTH readers resides in a hydrophobic pocket surrounded by a
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positively charged surface, rendering the YTH domain favourable to bind any methylated RNA
sequence. Of note, plant agenet members contain two plant agenet domains (Agenet1 and
Agenet2) in tandem, each harbouring an aromatic cage. Whilst the aromatic cage of Agenet2 is pro-
posed to be the site that binds methylated lysines (Adams-Cioaba et al., 2010), Agenet1 exhibits a
basic surface patch with potential for RNA binding (Myrick et al., 2015). The plant Agenet domain
of FMRP (1-134) has already been shown to harbour RNA-binding ability to RNA homopolymers,
with progressively increased affinity when testing longer FMRP constructs (1–180 and 1–214), sug-
gesting a cooperative effect between the positively charged residues distributed along the N-termi-
nus region (Milosevich and Hof, 2016). In a similar manner, the other domains present in SND1
cannot be disregarded in considering how SND1 may bind its target RNAs. Our RIP-seq data and
eCLIP analysis reveals for the first time that SND1 is indeed a bona fide RNA-binding protein acting
at the transcriptome level. Structural and biochemical analysis had already proposed that the N-ter-
minal region of SND1, specifically SN3 and SN4, possess RNA binding (Li et al., 2008), thus, in addi-
tion to the Tudor domain interacting with methylated RNA, the N-terminal region of SND1 most
likely also contributes to RNA binding and may play a significant role in determining which RNAs are
targeted by SND1, including those that are methylated.
Elucidating Royal domains structures in complex with m6A-ORF50-1 hairpin will help reveal the
reason for the distinct selectivity between YTH readers and Royal members and to elucidate to
which extent the aromatic cage of Royal domains plays a role in recognising m6A-modified RNA.
Moreover, these studies could lead to the development of small molecule inhibitors that specifically
block the aromatic cage of SND1 to hinder recognition of methylated ORF50 RNA for the treatment
of KSHV-related malignancies. Pioneering inhibitors for some methyl-lysine readers of the Tudor sub-
family and other Royal members are currently being investigated with success (Milosevich and Hof,
2016).
Our findings underscore the potential of other members from the ‘Royal family’ as putative new
regulators of m6A. Of the Tudor subfamily, the Tudor domain-containing (TDRD) proteins, AKAP1,
SMN and SPF30 display methyl-arginine-binding and are involved in RNA metabolism (Chen et al.,
2011), therefore these are ideal candidates to reveal more m6A readers. In contrast to the ubiqui-
tously expressed SND1, most of the mammalian TDRD proteins display male germline-enriched
expression and are essential for spermatogenesis (Chen et al., 2011). It will be of interest to exam-
ine whether m6A-decorated RNAs are regulated post-transcriptionally via TDRD proteins during
germ cell differentiation. Notably, spermatid perinuclear RNA-binding protein (STRBP) was within
the top ten enriched proteins in m6A-ORF50-1 bait. The remainder members of the Tudor protein
subfamily bind methyl-lysine residues and contain other domains related to chromatin biology, con-
sequently, these proteins are unlikely to participate in RNA metabolism. The discovery of PSIP1,
HDGFRP2 and MSH6 as putative m6A readers is surprising as the PWWP domain is a well-estab-
lished nucleosome-binding domain and these proteins participate in DNA repair (Qin and Min,
2014). However, FMRP takes part in the DNA damage response (Alpatov et al., 2014) but FMRP is
also a RNA-binding protein that regulates the translation of its m6A-containing target RNAs
(Edupuganti et al., 2017). An m6A RNA-mediated response to UV-induced DNA damage was
recently reported (Xiang et al., 2017), as such, these PWWP proteins could represent a link between
methylation of RNA and DNA damage. In support of the putative m6A reading ability of these pro-
teins is the fact that mass spectrometry identification of PSIP1 short (p52) isoform, which includes
the PWWP domain, revealed that ~95% of interactors function in pre-mRNA processing. Moreover
this isoform co-localised with SRSF2 in nuclear speckles and modulated alternative splicing
(Pradeepa et al., 2012), thus the implication of these proteins in m6A RNA metabolism requires fur-
ther investigation.
Finally, it is worth pointing out the possibility that SND1 may be able to read other RNA methyl-
modifications in addition to m6A. Further studies characterising these methyl-modifications and their
corresponding readers will help resolve this matter.
In conclusion, our data supports the hypothesis that highly specialised domains such as the Royal
domains, which harbour a structurally-related aromatic cage to the one found in the YTH domain,
may be required for the selective and direct recognition of m6A, while proteins without aromatic
cages may not be able to directly read m6A.
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Materials and methods
Key resources table
Reagent
type (species)
or resource Designation
Source or
reference Identifiers
Additional
information
Strain,
strain background
(Escherichia coli)
BL21(DE3) Thermo
Scientific
Cat No. C600003 Competent cells
Cell line
(Homo sapiens)
HEK-293T ATCC Cat No. CRL-3216 The cell line is
commercially
available
at ATCC
Cell line
(Homo sapiens)
HEK-293 ATCC Cat No. CRL-1573 The cell line is
commercially
available
at ATCC
Cell line
(Homo sapiens)
TREx
BCBL1-Rta
A gift of JU Jung
(University of
Southern
California, USA).
Nakamura et al., 2003
Cell line
(Homo sapiens)
BCBL1 A gift from
Dr Andrew
Hislop (University of
Birmingham, UK).
Renne et al., 1996
Antibody Anti-m6A
(rabbit polyclonal)
Merck Millipore ABE572 m6A-seq and m6A-IP
Antibody Anti-SND1
(rabbit polyclonal)
Proteintech 10760–1-AP WB (1:1,000).
2 mg for RIP-seq
and RIP
2 mg per ChIP
Antibody Anti-SND1
(mouse monoclonal)
Proteintech 60265–1-Ig WB (1:1,000).
Antibody Anti-FXR1
(rabbit polyclonal)
Proteintech 13194–1-AP 2 mg per RIP
Antibody Anti-FXR2
(rabbit polyclonal)
Proteintech 12552–1-AP 2 mg per RIP
Antibody Anti-PSIP1
(rabbit polyclonal)
Proteintech 25504–1-AP 2 mg per RIP
Antibody Anti-METTL3
(rabbit polyclonal)
Bethyl
laboratories
A301-567A WB (1:500)
Antibody Anti-FTO
(rabbit monoclonal)
Abcam ab126605 WB (1:5,000)
Antibody Anti-YTHDF1
(rabbit polyclonal)
Proteintech 17479–1-AP WB (1:1,000)
1 mg per RIP
Antibody Anti-YTHDF2
(rabbit polyclonal)
Abclonal A9639 WB (1:500)
Antibody Anti-YTHDF3
(rabbit polyclonal)
Abclonal A8395 WB (1:500)
5.8 mg per RIP
Antibody Anti-ORF57
(mouse monoclonal)
Santa Cruz sc-135746 WB (1:1,000)
Antibody Anti-RTA
(rabbit polyclonal)
A gift from
Professor
David Lukac
(Rutgers, New
Jersey, USA)
Lukac et al., 1998 WB (1:1,000)
Continued on next page
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Continued
Reagent
type (species)
or resource Designation
Source or
reference Identifiers
Additional
information
Antibody Anti-ORF54
(mouse monoclonal)
A gift from
Friedrich Gra¨sser
(University of
Homburg,
Germany)
Kremmer et al., 1999 WB (1:1,000)
Recombinant
DNA reagent
FLAG-ORF50
plasmid (pCDH-CMV-
MCS-EF1-Puro)
for mammalian
expression
NovoPro Bioscience Custom made. Purchased from NovoPro,
available upon request
from the Whitehouse
laboratory.
Recombinant
DNA reagent
GST-SND1-C-terminus
(residues 548–910) for
bacteria expression
NovoPro Bioscience Custom made. Purchased from NovoPro,
available upon request
from the Whitehouse
laboratory.
Recombinant
DNA reagent
GST-FXR1-plant agenet
(residues 2–132) for
bacteria expression
NovoPro Bioscience Custom made. Purchased from NovoPro,
available upon request
from the Whitehouse
laboratory.
Recombinant
DNA reagent
GST-PSIP1-PWWP
(residues 3–100) for
bacteria expression
NovoPro Bioscience Custom made. Purchased from NovoPro,
available upon request
from the Whitehouse
laboratory.
Recombinant
DNA reagent
GST-CBX3-Chromo
(residues 29–86) for
bacteria expression
NovoPro Bioscience Custom made. Purchased from NovoPro,
available upon request
from the Whitehouse
laboratory.
Sequence-
based reagent
Mission TRC shRNA
SND1 KD1
Sigma TRCN0000245143 Mission TRC shRNA
bacterial glycerol stock
commercially available
from Sigma
Sequence-
based reagent
Mission TRC shRNA
SND1 KD2
Sigma TRCN0000049656 Mission TRC shRNA
bacterial glycerol stock
commercially available
from Sigma
Commercial
assay or kit
RNA fragmentation
reagent
Thermo Scientific AM8740
Commercial
assay or kit
Pierce chromatin
prep module
Thermo Scientific 26158
Commercial
assay or kit
LightShift chemilu
minescent
RNA EMSA Kit
Thermo Scientific 20158
Commercial
assay or kit
EZ-ChIP Merck Millipore 17–371
Commercial
assay or kit
DNA-free DNA
Removal Kit
Thermo Scientific AM1906
Chemical
compound,
drug
3-deazaadenosine
(DAA)
Cambridge
Bioscience
9000785–5 mg
Software,
algorithm
m6aViewer 1.6
software
dna2.leeds.ac.uk/m6a/ Antanaviciute
et al., 2017
Published in the
RNA journal.
2017 Oct; 23(10):
1493–1501.
Other Magna ChIP
Protein A+G
magnetic beads
Merck Millipore 16–663 Used for m6A-seq
and RIP-seq
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Cell lines and reagents
HEK-293T and HEK-293 cells were purchased from ATCC (American Type Culture Collection) and
cultured in Dulbecco’s modified Eagle’s medium with glutamine (DMEM, Lonza) supplemented with
10% (v/v) fetal calf serum (FCS) (Gibco) and 1% (v/v) penicillin-streptomycin (P/S) (Gibco). TREx
BCBL1-Rta cells, a BCBL1-based, primary effusion lymphoma (PEL) B cell line that has been engi-
neered to inducibly express exogenous Myc-tagged RTA by the addition of doxycycline, were a gift
of JU Jung (University of Southern California, USA). BCBL1 cells were a gift from Dr Andrew Hislop
(University of Birmingham, UK). BCBL1 cells were grown in RPMI1640 growth medium with gluta-
mine (Gibco) supplemented with 10% (v/v) FCS (Gibco) and 1% (v/v) P/S (Gibco). TREx BCBL1-Rta
cells were grown in RPMI1640 growth medium with glutamine (Gibco) supplemented with 10% (v/v)
FCS, (Gibco), 1% P/S (v/v) (Gibco) and 100 mg/mL hygromycin B (Thermo Scientific). All cell lines
were tested negative for mycoplasma. For virus reactivation, TREx BCBL1-Rta cells were induced
using 2 mg/mL doxycycline hyclate (Sigma-Aldrich) and BCBL1 cells were induced using 2 mM
sodium butyrate (Sigma-Aldrich). Antibodies used in Western blotting are listed below: anti-SND1
(Proteintech, 10760–1-AP, 1:1,000); anti-SND1 (Proteintech, 60265–1-Ig, 1:1,000); anti-METTL3
(Bethyl, A301-567A, 1:500); anti-FTO (Abcam, ab126605, 1:5,000); anti-YTHDF1 (Proteintech,
17479–1-AP, 1:1,000); anti-YTHDF2 (Abclonal A9639, 1:500); anti-YTHDF3 (Abclonal, A8395, 1:500);
anti-ORF57 (Santa Cruz, sc-135746 1:1,000); anti-GAPDH (Abcam, ab8245 1:5,000); anti-PARP (CST,
9542 1:2,500), the rabbit polyclonal anti-RTA was a gift from Professor David Blackbourn (University
of Surrey, UK) and used at 1:1000. The mouse monoclonal anti-ORF54 was a gift from Friedrich
Gra¨sser (University of Homburg, Germany) and used at 1:1000. Rabbit anti-m6A antibody (ABE572)
(Merck Millipore) was used in m6A-immunoprecipitations. Antibodies used in RIP are as follows: anti-
SND1 (Proteintech, 10760–1-AP); anti-FXR1 (Proteintech, 13194–1-AP); anti-FXR2 (Proteintech,
12552–1-AP); anti-PSIP1 (Proteintech, 25504–1-AP); anti-YTHDF1 (Proteintech, 17479–1-AP); anti-
YTHDF3 (Abclonal, A8395) and normal rabbit IgG (Merck Millipore, 12–370). 3-deazaadenosine
(DAA) was purchased from Cambridge Bioscience. For RIPs, either 2 mg of anti-SND1, FXR1, FXR2,
PSIP1 or normal rabbit IgG were used per RNA immunoprecipitation. For YTHDF1 and YTHDF3, 1
and 5.8 mg were used per immunoprecipitation respectively. For ChIP experiments, 2 mg of a-RNAPII
(clone CTD4H8) antibody (Merck Millipore), anti-SND1 (Proteintech, 10760–1-AP) or normal rabbit
IgG (Merck Millipore, 12–370) were used per chromatin immunoprecipitation. The same lot number
(00020506) of SND1 antibody (Proteintech, 10760–1-AP) was used for western blot, RIP-seq, RIP-
qPCR and ChIP experiments.
m6A-seq
Total RNA from TREx BCBL1-Rta cells was extracted using TRIzol (Thermo Scientific) according to
the supplier’s protocol. DNA-free DNA Removal Kit (Ambion) was used to remove any contaminat-
ing DNA from RNA samples. Isolated RNA was purified by standard ethanol precipitation and 100
mg of total RNA was fragmented with RNA fragmentation reagent (Ambion) according to the manu-
facturer’s protocol. Fragmented RNA was ethanol-precipitated and re-suspended in 10 ml of RNase-
free water and stored at  80˚C. 2 mg of total fragmented RNA was saved as input RNA for later use
in cDNA library construction. For each m6A-immunoprecipitation (m6A-IP), 25 ml of slurry of Magna
ChIP Protein A+G magnetic beads (Merck Millipore) were washed twice with IP/wash buffer [20 mM
Tris HCl pH 7.4, 150 mM NaCl, and 0.1% NP-40 (v/v)]. Beads were re-suspended in 100 ml of IP/wash
buffer and coated with 5 mg of rabbit anti-m6A antibody (ABE572) (Merck Millipore) for 45 min at
room temperature with rotation. Beads were then washed three times with IP/wash buffer and IPs
were prepared by mixing the antibody-coated beads with 900 ml of IP/wash buffer, 35 ml of 0.5 M
EDTA pH 8.0, 4 ml of RNasin Plus (Promega) and 100 mg of fragmented RNA. IPs were incubated
overnight at 4˚C with rotation. Beads were then washed six times with IP/wash buffer. IP samples
were further incubated with 126 ml of IP/wash buffer, 15 ml of 10% SDS (v/v) and 9 ml of PCR-grade
proteinase K (20 mg/mL) (Thermo Scientific) for 30 min at 55˚C. After incubation, the supernatant
containing the RNA was transferred to a new microcentrifuge tube and 250 ml of IP/wash buffer was
added to each sample. RNA was purified with the use of phenol:chloroform:isoamyl alcohol (Sigma-
Aldrich) and finally sodium acetate/ethanol-precipitated together with 1 ml of RNA-grade glycogen
(Thermo Scientific) to allow visualisation of the RNA pellet. Several m6A-IPs (four to six) were pooled
to provide enough sample for cDNA library construction and next-generation sequencing (NGS) as
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described below. 1.5 to 3 ng of RNA from input and m6A-IPs were used for NGS library production
using NEBNext Ultra kit (NEB) according to the manufacturer’s protocol. Libraries for the first bio-
logical replicate were sequenced on a HiSeq 2500 platform (Illumina) with 101 bp paired-end lane.
Libraries from the second biological replicate were sequenced on a HiSeq 3000 platform (Illumina)
with 151 bp paired-end lane. For m6A-seq two independent biological replicates were prepared for
each time point analysed (0 hr, 8 hr and 20 hr post-reactivation).
RIP-seq
TREx BCBL1-Rta cells remained unreactivated or were reactivated for 8 or 20 hr. At the desired time
point a fraction of the cells was removed to serve as input RNA to control for RNA expression and
stored in TRIzol (Thermo Scientific) at  80˚C. For each RNA immunoprecipitation (RIP), 7  106 cells
were used. Cells were fixed with 1% (v/v) formaldehyde (Calbiochem) for 10 min at room tempera-
ture. Crosslinking was stopped by addition of glycine at a final concentration of 125 mM for 5 min.
Cells were washed with PBS (Lonza) and re-suspended in 200 ml of ice-cold shearing buffer [50 mM
Tris HCl pH 7.4, 100 mM NaCl and 0.1% (v/v) NP-40] supplemented with Complete, EDTA-free pro-
tease inhibitors (Roche) and 1 ml of murine RNase inhibitor (NEB). Samples were then sonicated with
an EpiShear multi-sample sonicator (Active Motif) with pulses of 30 s of sonication followed by a 30 s
rest for a total of 12 min at 30% amplitude. Polystyrene sonication tubes (Active Motif) were used to
achieve efficient sonication. After sonication, samples were centrifuged at 12,000 x g for 10 min at 4˚
C and the supernatant was used immediately in RIPs. For each RIP, 25 ml of slurry of Magna ChIP
Protein A+G magnetic beads (Merck Millipore) were coated with the antibody of interest as previ-
ously described for m6A-seq. RIPs were prepared by mixing the antibody-coated beads with 800 ml
of IP/wash buffer [20 mM Tris HCl pH 7.4, 150 mM NaCl, and 0.1% NP-40 (v/v)], 35 ml of 0.5 M
EDTA pH 8.0, 4 ml of murine RNase inhibitor (NEB) and 200 ml of lysate containing fragmented RNA.
RIPs were incubated for 3 hr at 4˚C with rotation. Beads were then washed six times as previously
described (Gilbert and Sj, 2006). RIP samples were then further incubated with 200 ml of IP/wash
buffer, 2 ml of PCR-grade proteinase K (20 mg/mL) (Thermo Scientific), 4 ml of 5M NaCl and 0.5 ml of
murine RNase inhibitor (NEB) for 1 hr at 60˚C. After incubation, the supernatant containing the RNA
was transferred to a new microcentrifuge tube and 50 ml of IP/wash buffer was added to each sam-
ple. RNA was purified as described for m6A-seq but instead of using phenol:chloroform:isoamyl
alcohol for purification, TRIzol LS (Thermo Scientific) was used according to the manufacturer’s
instructions. DNA-free DNA Removal Kit (Ambion) was used to remove any contaminating DNA
from RIP RNA samples. Total RNA from input samples was isolated with the use of TRIzol (Thermo
Scientific) according to the supplier’s protocol and treated with DNase I using the DNA-free DNA
Removal Kit (Ambion). Input RNA was saved without applying sonication because we observed lower
quality sequencing libraries when using sonicated input RNA than when using input RNA that was
heat-fragmented. Saved input RNA was therefore heat-fragmented for 8 min at 94˚C before pro-
ceeding with library construction. Due to the large size of RNA fragments observed after SND1
immunoprecipitation, isolated RNA from RIP samples was further fragmented for 7 min at 94˚C
before first strand synthesis. 100 to 200 ng of each input and RIP sample was used for NGS libraries
which were made using the TruSeq Stranded Total RNA library production kit (Illumina) according to
the manufacturer’s protocol. All samples were multiplexed and sequenced on two 151 bp paired-
end lanes on a HiSeq 3000 instrument (Illumina). For RIP-seq, two independent biological replicates
were prepared for each time point analysed (0 hr, 8 hr and 20 hr post-reactivation). Additionally, for
one biological replicate, two technical replicates were deep-sequenced for all RIP samples. A third
biological replicate RIP sample at 0 hr was also deep-sequenced.
RNA-seq
NGS libraries were generated from two independent biological replicates using scramble and SND1
KD2 TREx BCBL1-Rta cells both during latency and after 24 hr of lytic reactivation. Two independent
biological replicates from scramble and SND1 KD2 BCBL1 cells both during latency and after 24 hr
of lytic reactivation were also deep-sequenced. Libraries were made using TruSeq Stranded Total
RNA library preparation kit (Illumina) according to the manufacturer’s protocol. Libraries were
sequenced on 151 bp paired-end lanes on a HiSeq 3000 instrument (Illumina).
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m6A-IP-qPCR and RIP-qPCR
m6A-IPs and RIPs were carried out as described above respectively, with the following modification.
1% input samples (10 ml from the 1 mL IP reaction) were removed before immunoprecipitation and
stored at  80˚C. Input samples were processed together with immunoprecipitated samples from the
proteinase K treatment onwards. Purified input and immunoprecipitated RNA was resuspended in
10 ml of RNase-free water and reverse transcribed as described in the RT-qPCR analysis section.
qPCR normalisation was performed similarly to chromatin immunoprecipitation (ChIP) coupled to
detection by qPCR analysis using DDCt method (relative quantification). An example for m6A-IPs fol-
lows. Each m6A-IP sample Ct value for each primer used was normalised to the corresponding input
Ct value: DCt normalised m6A-IP = Ct m6A-IP – [Ct Input –log2 (Input dilution factor)]. Input dilution
factor = (fraction of the input reaction saved) 1. As 1% input was saved, the dilution factor is 100 or
6.644 cycles (i.e. log2 of 100). Percentage of recovery from the initial reaction (% input) was then cal-
culated for each primer as 100 x Amplification efficiency (AE) (-DCt normalised m6A-IP). m6A enrichment
was finally calculated as the fold change between the % input for a region containing m6A peaks
over the % input for a negative control region. SND1 enrichment was calculated as the fold change
between the % input for a region of interest over the % input for a region of a non-target control
RNA such as 18S rRNA. For HEK-293 cells, RIP-qPCR was performed the same way as described for
TREx BCBL1-Rta cells with the exception that the sonication time was reduced to eight min and 50
mg of fragmented RNA were used per IP.
Processing of raw deep-sequencing data and quality control
All m6A-seq, RIP-seq and RNA-seq data were generated at the next-generation sequencing facility
of the University of Leeds, United Kingdom. Data were extracted and de-multiplexed using bcl2fastq
Conversion software (Ilumina), which exports a matched pair (read 1 and read 2) of compressed
fastq files per sample. Quality control of all sequence data, including publicly available datasets, was
carried out using FastQC software (Andrews, 2010), which allowed the identification of sequence
adapter contamination, overrepresented sequences, estimation of the PCR and optical duplicate
rate and overall sequencing quality. All raw sequence data were then processed using Cutadapt
software (Martin, 2011) in order to remove poor quality bases (quality score less than 20) as well as
Illumina universal sequencing adapter sequence (AGATCGGAAGAG) from the 3’ end of reads.
Orphan read pairs were discarded. Reads shorter than 25 bp after trimming were discarded to limit
ambiguous alignments in downstream processing.
Next-generation sequencing data alignment and quality control (QC)
The KSHV reference genome sequence was downloaded in FASTA format from the NCBI website,
while a gene transfer format (GTF) file containing genomic feature coordinates (ORFs, genes, exons,
UTRs) was assembled manually using data from the KSHV 2.0 annotation dataset (Arias et al.,
2014). The human hg38 reference genome sequence was downloaded from the FTP-UCSC genome
browser (Kent et al., 2002) in FASTA format. The human hg38 genome annotation was downloaded
using the UCSC Table Browser Tool (Karolchik, 2004). KSHV data were manually added to the
human reference FASTA and GTF files as an additional contig. The genome sequences in the
merged FASTA file were indexed for alignment using STAR software (Dobin et al., 2013). Paired-
end sequence data was subsequently aligned to this index using the splice-aware read aligner STAR,
in paired-end, two-pass mode. Aligned reads in binary alignment map (BAM) format were sorted by
coordinate and indexed using Samtools (Li et al., 2009) and PCR and optical duplicates flagged for
additional QC checks (but not removed) using Picard Tools software. Additional QC metrics were
assembled and assessed using multiQC software (Ewels et al., 2016).
m6A-seq data analysis
m6A peaks were called using m6aViewer software version 1.6 (Antanaviciute et al., 2017) with
default settings and exported to tab-delimited format for additional analyses in R. To define signifi-
cantly enriched m6A peaks in both viral and cellular RNAs, a minimum fold change of m6A-IP reads
over input reads of 1.5 in addition to a false discovery rate of 5% (FDR < 5%) was required in both
biological replicates. Peaks positions were considered overlapping between replicates if the calls
were within 100 nucleotides between corresponding positions. To determine the number of SND1
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RNA targets identified by transcript-wide analysis that are m6A-modified, a more stringent m6A
peak calling cut-off was used to compliment a more stringent SND1 RIP cut-off, with a minimum of
100 read paired at the tallest point in the m6A peak and a 2-fold enrichment of m6A-IP reads over
input reads using a FDR < 1%. For target overlap between heterologously expressed YTH readers
and SND1, high-confidence SND1-bound genes (summarised at HGNC gene symbol annotation
level, where multiple Ensembl genes mapped to a symbol, the longest was used) were defined at a
cut-off of FDR < 1% and a minimum of 2-fold RIP enrichment over input, while m6A peaks were used
as before (FDR < 5%, 1.5 fold minimum enrichment in both replicates).
Peak motif discovery was performed by exporting the flanking 100 base of RNA sequence sur-
rounding peaks in KSHV methylome to a FASTA file using m6aViewer software. Sequences contain-
ing repetitive viral sequence were removed. The remaining data was then used for enriched
sequence motif detection using the MEME software (Bailey et al., 2009), with scrambled sequences
used as a control. KSHV methylome maps were produced using custom Java code.
RIP-seq data analysis
SND1 binding sites were initially identified at transcript-level resolution by counting reads in the
SND1 immunoprecipitated (RIP) and input (control) sample data that mapped to each RefSeq and
KSHV transcripts. R package Rsubread (Liao et al., 2014) was used to obtain raw read counts as fol-
lows. Each uniquely mapping read pair was counted towards the total transcript count for each sam-
ple, while multi-mapping reads were counted as partial reads, based on the number of mapped
positions. Since the library preparation protocol preserved the strand of the original RNA molecule,
only ‘correctly’ stranded read pairs were counted for each transcript. DESeq2 R package
(Love et al., 2014) was used to normalise the data and identify transcripts that showed a significant
increase in the coverage of the normalised RIP samples when compared to the input controls. In
order to increase the resolution of the SND1-bound regions, custom Java code was used that identi-
fied transcriptome regions that were enriched in the RIP data when compared to the control data.
Initially, the application segmented regions into intronic or exonic sequences: a region was classified
as exonic if the sequence was present in at least one mature transcript. The per-base raw read cover-
age was determined for both intronic and exonic sequences and normalised using the size factors
determined from the earlier normalisation step (DESeq2) to account for library compositions and
sizes. Using a sliding window approach, first each mature transcript or intron was divided into con-
tiguous segments that loosely showed putative enrichment in the RIP data (>1 fold enrichment) com-
pared to the input data and those that putatively were depleted in (or equal to) RIP (1 fold
enrichment). Low coverage segments (<20 reads in RIP) were filtered out as quality control. All data
from the different samples in the analysis were then merged to generate a single dataset that con-
tained read depth data for all consensus segments identified this way, both intronic and exonic.
Each segmented region was subsequently treated as an individual ‘gene’ for re-analysis using
DESeq2, specifically testing for RIP signal enrichment over input (alternative hypothesis: normalised
segment read coverage in RIP greater than in input) in order to identify regions with a significant
increase in RIP over input signal.
Differential expression and functional enrichment analyses
Differential expression analyses were performed in R using DESeq2 package. Functional enrichment
analyses were performed using the clusterProfiler R package (Yu et al., 2012), using the significance
cut-off of <0.05 (Benjamini-Hochberg corrected p-values), with all expressed/detected genes (at
least one mapped read pair) used as a background control.
Splicing analysis
Alternative splicing events were detected using Comprehensive AS Hunting (CASH) (Wu, 2017). In
addition, the lack of statistically significant splicing events between scramble and SND1-depleted
TREx BCBL1-Rta cells highlighted by CASH was also confirmed using Spladder software
(Kahles et al., 2016) and DEXSeq R package (Anders et al., 2012) for detecting differential exon
usage (data not shown). Read coverage and splicing graphs were visualised using Integrative Geno-
mics Viewer (IGV) (Robinson et al., 2011).
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Publicly available deep-sequencing data
Data downloaded from public repositories were aligned as above, except without the addition of
KSHV sequence to the reference genome. The following data were obtained from NCBI’s GEO data-
base as raw FASTQ files: HeLa cell line YTHDF1 PAR-CLIP data, two replicates (accessions:
GSM1553242, GSM1553243); HeLa cell line YTHDF2 PAR-CLIP data, three replicates (accessions:
GSM1197605, GSM1197606, GSM1197607); HeLa cell line YTHDF3 PAR-CLIP data, three replicates
(accessions: GSM2424844, GSM2424845, GSM2424846). HepG2 cell line m6A-seq data, four repli-
cates (accessions: GSM2409802, GSM2409803, GSM2715523, GSM2715524). Two replicates of each
eCLIP experiment were obtained from the ENCODE database as narrowPeak bed files: HepG2 FXR2
(accessions: ENCFF702QGF, ENCFF638WRZ); HepG2 SND1 (ENCFF471JAQ, ENCFF761CYV);
IGF2BP1 (accessions: ENCFF705SDK, ENCFF145YYK); IGF2BP3 (accessions: ENCFF076GHL,
ENCFF998WZW); TIAL1 (accessions: ENCFF302ROS, ENCFF467UOO).
eCLIP analysis
Binding sites from eCLIP experiments were downloaded from ENCODE as narrowPeak bed files.
Clusters from replicate one which directly overlapped clusters in replicate two were extracted and
kept for downstream analyses. To look at overlaps between eCLIP sites and m6A peaks, HepG2 RIP-
seq data was processed with m6aViewer 1.6 software, using default settings, and overlapping peaks,
containing a  1.5 fold increase of m6A-IP reads over input with a FDR < 5% across both replicates
were kept. De novo motif analysis of HepG2 m6A-seq and eCLIP sites was performed by feeding
peaks into the findMotifsGenome.pl function within the HOMER suite (version 4.9.1) using parame-
ters ‘-rna -len 5’. For SND1 motif discovery over m6A exonic regions, exons containing m6A-seq
peaks were identified and these whole exon sequences were screened for SND1 peaks. The SND1
peaks within this set of m6A-modified exons were used for motif discovery.
Supplementary m6A-seq and RIP-seq data
Excel data sheet for all m6A peaks called in both biological replicates is supplied as
Supplementary file 4. Excel data sheet for all SND1 targets identified by transcript-wide analysis is
supplied as Supplementary file 5.
Data availability
All deep-sequencing data discussed in this publication have been deposited in NCBI’s GEO Data-
base, GEO accession number GSE119026. All identified peptides/PSMs for each RNA bait can be
found in Supplementary file 7–15.
RNA affinity chromatography and RNA baits sequences
The following biotin-labelled RNA oligonucleotides were centred on the closest GGACU motif to
the m6A peaks detected in ORF37 and ORF50 transcripts. For each oligo, one oligo was m6A-modi-
fied at the GGACU motif while the control bait remained unmodified. For the ORF37 bait the
sequences used were: 5´-biotin-CGGAAAGCUGGCACUGAAGG-m6A-CUUCUUCUAUAGCA
UUUCCA-3´ and 5´-biotin-CGGAAAGCUGGCACUGAAGGACUUCUUCUAUAGCAUUUCCA-3´. Baits
spanning an m6A consensus in the first m6A peak identified in ORF50 (ORF50-1) were: 5´-biotin-
UUUGCCAAUCCUGGAGCCAGG-m6A-CUGUUGCCGGCUUCCAUGGUA-3´ and 5´-biotin-UUUGC-
CAAUCCUGGAGCCAGGACUGUUGCCGGCUUCCAUGGUA-3´. The sequences for baits spanning
an m6A consensus in the fourth m6A peak identified in ORF50 (ORF50-4) were: 5´-biotin-GUUG
UCCAGUAUUCUGCAAGG-m6A-CUGUACCAGCUGGACACGCCA-3´ and 5´-biotin-GUUGUCCAG
UAUUCUGCAAGGACUGUACCAGCUGGACACGCCA-3´. Cropped versions of ORF50-1 (cORF50-1)
were: 5´-biotin-GGAGCCAGG-m6A-CUGUUGCCGGCUUC-3´ and 5´-biotin-GGAGCCAGGACUG
UUGCCGGCUUC-3´. Stable versions of ORF50-1 (sORF50-1) were: 5´-biotin-UUGGCCCAUCCCG-
GAGCCAGG-m6A-CUGUUGCCGGCUUCCGGGGCC-3´ and 5´-biotin-UUGGCCCAUCCCGGAGC-
CAGGACUGUUGCCGGCUUCCGGGGCC-3´.
All baits were purchased from Integrated DNA Technologies (IDT).
TREx BCBL1-Rta cells were reactivated with doxycycline for 24 hr followed by lysis of the cells for
25 min in lysis buffer [10 mM NaCl, 2 mM EDTA, 0.5% (v/v) triton X-100, 0.5 mM DTT and 10 mM
Tris HCl, pH 7.4] containing complete protease inhibitor cocktail (Roche) and phosphatase inhibitor
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cocktail 2 (Sigma-Aldrich). Lysates were centrifuged at 4˚C for 10 min at 12,000 x g to pellet cell
debris and the supernatant was kept. 1000 mg of protein per pull-down in an approximate volume of
200 ml were supplemented with 40 units of RNasin Plus (Promega) and 50 mg of yeast tRNA (Sigma-
Aldrich) and pre-cleared with 30 ml (resin volume) of streptavidin-conjugated agarose beads (Merck
Millipore) for 3 hr at 4˚C with rotation. The final volume of the binding reaction was topped to 1 mL
with binding buffer (150 mM KCl, 1.5 mM MgCl2, 0.05% (v/v) NP-40, 0.5 mM DTT, 10 mM Tris HCl,
pH 7.4). While pre-clearing, 30 ml (resin volume) of streptavidin-conjugated agarose beads per pull-
down were blocked with 1% (w/v) BSA (Sigma-Aldrich) in PBS (Lonza) and 50 mg of yeast tRNA
(Sigma-Aldrich). Pre-cleared lysates were then mixed with the blocked beads and 4 mg of each bioti-
nylated RNA oligo were added per pull-down. Input samples were immediately collected and stored
at  80˚C until further use. RNA baits were incubated for 2 hr at 4˚C with rotation followed by five
washes with binding buffer. Proteins were released from the beads by heating at 95˚C for 5 min in
30 ml of 2 X Laemmli sample buffer. Input and pull-down samples were used for either Western blot-
ting or LC-MS/MS analysis.
Mass spectrometry analysis
LC-MS/MS was performed at the proteomics facility of the University of Bristol, United Kingdom.
Samples were separated using SDS-PAGE until the dye front had migrated approximately one centi-
metre into the separating gel. Each gel lane was then excised and subjected to in-gel tryptic diges-
tion using a DigestPro automated digestion unit (Intavis Ltd.). The resulting peptides were
fractionated using an Ultimate 3000 nano-LC system in line with an LTQ-Orbitrap Velos mass spec-
trometer (Thermo Scientific). In brief, peptides in 1% (v/v) formic acid were injected onto an Acclaim
PepMap C18 nano-trap column (Thermo Scientific). After washing with 0.5% (v/v) acetonitrile 0.1%
(v/v) formic acid, peptides were resolved on a 250 mm 75 mm Acclaim PepMap C18 reverse phase
analytical column (Thermo Scientific) over a 150 min organic gradient, using seven gradient seg-
ments (1–6% solvent B over 1 min., 6–15% B over 58 min., 15–32%B over 58 min., 32–40%B over 5
min., 40–90%B over 1 min., held at 90%B for 6 min and then reduced to 1%B over 1 min.) with a
flow rate of 300 nl min 1. Solvent A was 0.1% formic acid and Solvent B was aqueous 80% acetoni-
trile in 0.1% formic acid. Peptides were ionised by nano-electrospray ionisation at 2.1 kV using a
stainless-steel emitter with an internal diameter of 30 mm (Thermo Scientific) and a capillary tempera-
ture of 250˚C. Tandem mass spectra were acquired using an LTQ- Orbitrap Velos mass spectrometer
controlled by Xcalibur 2.1 software (Thermo Scientific) and operated in data-dependent acquisition
mode. The Orbitrap was set to analyse the survey scans at 60,000 resolution (at m/z 400) in the mass
range m/z 300 to 2000 and the top twenty multiply charged ions in each duty cycle selected for MS/
MS in the LTQ linear ion trap. Charge state filtering, where unassigned precursor ions were not
selected for fragmentation, and dynamic exclusion (repeat count, 1; repeat duration, 30 s; exclusion
list size, 500) were used. Fragmentation conditions in the LTQ were as follows: normalised collision
energy, 40%; activation q, 0.25; activation time 10 ms; and minimum ion selection intensity, 500
counts. The raw data files were processed and quantified using Proteome Discoverer software v1.4
(Thermo Scientific) and searched against the UniProt Human database (downloaded October 2015;
131351 sequences) plus KSHV protein sequences using the SEQUEST algorithm. Peptide precursor
mass tolerance was set at 10ppm, and MS/MS tolerance was set at 0.8 Da. Search criteria included
carbamidomethylation of cysteine (+57.0214) as a fixed modification and oxidation of methionine
(+15.9949) as a variable modification. Searches were performed with full tryptic digestion and a max-
imum of 1 missed cleavage was allowed. The reverse database search option was enabled and all
peptide data was filtered to satisfy false discovery rate (FDR) of 5%.
Comparative reports were produced between methylated and control RNA baits, the data were
filtered at 5% FDR and had also removed any proteins that were only matched by a single peptide.
In addition, the data was sorted based on the number total number of peptide spectrum matches
(PSM’s) identified, such that those proteins at the top of the list were only identified in the methyl-
ated samples (e.g. no peptides matching that protein were detected in the non-methylated sample).
Comparative reports for ORF50-1, ORF50-4 and ORF37 baits are supplied as Supplementary file 7,
8 and 9 respectively. To uncover putative m6A readers, all proteins identified for a given methylated
and control bait were sorted by total number of PSM’s for the m6A bait. Proteins were then classi-
fied as enriched in methylated baits if the number of PSM’s assigned to the protein was at least
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double in the methylated bait compared with the control bait. All identified unique peptides and
PSMs for all RNA baits can be accessed on Supplementary file 10–15.
Gene-annotation enrichment analysis were performed with The Database for Annotation, Visuali-
sation and Integrated Discovery (DAVID) v6.8.
RNA secondary structure prediction
RNA secondary structure prediction of baits was carried out using UNAfold web server
(Zuker, 2003).
Recombinant protein expression
All recombinant proteins were gene synthesised (NovoPro Bioscience), cloned into pGEX-4T-1 vec-
tor (NovoPro Bioscience) and expressed in E. coli strain BL21-DE3 (Thermo Scientific). GST-recombi-
nant proteins contained the FXR1 plant agenet domain (residues 2–132) which includes Agenet1 and
Agenet2 in tandem, the PSIP1 PWWP domain (residues 3–100) or the CBX3 chromodomain (residues
29–86). SND1-C-terminus comprises of residues 548–910. Recombinant GST plasmid was commer-
cially available (GE healthcare). Recombinant proteins were produced by lowering the temperature
to 18˚C and inducing the culture with 0.2 mM IPTG for 20 hr. Bacteria pellet from 1 L culture was re-
suspended with 30 mL of lysis buffer [50 mM Tris HCl, pH 7.5, 150 mM NaCl, 0.05% (v/v) NP-40 and
freshly added 0.25 mg/mL lysozyme (Sigma-Aldrich)] and incubated on ice for 45 min. The lysate was
then sonicated using a MSE Soniprep 150 sonicator (12 cycles of 20 s pulse-on and 20 s pulse-off).
The lysate was centrifuged at 12,000 x g for 15 min at 4˚C. The supernatant was incubated with glu-
tathione agarose beads (GE healthcare) for 2 hr at 4˚C. The resin was washed twice with lysis buffer
and once with 50 mM Tris HCl, pH 7.4. Protein was eluted from the beads using 50 mM Tris HCl
with 20 mM reduced glutathione (Sigma-Aldrich) that had been adjusted to a final pH of 7.4.
Electrophoretic mobility shift assays (EMSAs)
EMSAs were carried out using LightShift chemiluminescent RNA EMSA Kit (Thermo Scientific)
according to the manufacturer’s instructions. Binding reactions consisted of kit supplied 1 X binding
buffer (10 mM HEPES, pH 7.3, 20 mM KCl, 1 mM MgCl2 and 1 mM DTT) supplemented with 5% (v/
v) glycerol. For EMSAs in the presence of herring sperm DNA (Promega), DNA was mixed and incu-
bated in the binding reaction. Note that this sperm DNA is provided after phenol-chloroform extrac-
tion, ethanol precipitation and sonication, which produces single-stranded fragments. Binding
reactions were incubated with increasing amounts of recombinant protein which was freshly isolated
(e.g. no more than two days after purification from bacteria and stored at 4˚C). The same biotiny-
lated baits used in the RNA affinity experiments were used for EMSAs. All baits were used at 3.75
nM oligo final concentration, except for cORF50-1 which was used at 16 nM. Binding reactions were
incubated for 30 min at room temperature. 10 ml reactions were mixed with 2 ml of 5 X loading dye
and 10 ml were loaded onto a 6% (w/v) non-denaturing polyacrylamide gel in 1 X TAE buffer (40 mM
Tris, 20 mM acetate and 1 mM EDTA/NaOH pH 8.0). Gels were ran for 45 min at 100V and trans-
ferred to a nylon membrane (GE healthcare) via wet transfer with 1 X TAE as transfer buffer for 45
min at 400 mA. RNA was crosslinked to the membrane at 120mJ/cm2 using a CL-1000 ultraviolet
crosslinker (UVP). The rest of the protocol was performed as described in the kit manual. Biotiny-
lated baits were visualised after exposure to an ultra-sensitive ECL (SuperSignal west femto maxi-
mum sensitivity substrate) (Thermo Scientific) and exposed to Amersham hyperfilm ECL (GE
Healthcare).
Site-directed mutagenesis
A FLAG tag ORF50 gene which included both ORF50 exons and the ORF50 intron cloned into a
pCDH-CMV-MCS-EF1-Puro vector was purchased from NovoPro Bioscience. Single point mutations
in this plasmid were generated using QuickChange II site-directed mutagenesis kit (Stratagene)
according to the manufacturer’s instructions. All plasmids containing the desired mutation were con-
firmed by DNA sequencing (Eurofins Genomics). To mutate the GGACT motif present in ORF50-1
bait the following primers were used: TCCTGGAGCCAGGATTGTTGCCGG (forward), CCGGCAA-
CAATCCTGGCTCCAGGA (reverse). To mutate the GGACT motif present in ORF50-4 bait these
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primers were used: TCCAGTATTCTGCAAGGATTGTACCAGCTGGACAC (forward), GTGTCCAGC
TGGTACAATCCTTGCAGAATACTGGA (reverse).
shRNA stable cell lines
Lentiviruses were generated by transfection of HEK-293T cells seeded in 12-well plates using a
three-plasmid system. Per 12-well, 4 ml of lipofectamine 2000 (Thermo Scientific) were used together
with 1 mg of pLKO.1 plasmid expressing shRNA against the protein of interest, 0.65 mg of pVSV.G,
and 0.65 mg psPAX2. pVSV.G and psPAX2 were a gift from Dr. Edwin Chen at the University of
Leeds. 8 hr post-transfection, medium was changed into 1.5 mL of DMEM supplemented with 10%
(v/v) FCS. Two days post-transfection viral supernatants were harvested, filtered through a 0.45 mm
filter (Merck Millipore) and immediately used for transductions of TREx BCBL1-Rta or BCBL1 cells.
One mL of each 12-well plate was used to infect 500,000 cells by spin inoculation for 60 min at 800 x
g at room temperature, in the presence of 8 mg/mL of polybrene (Merck Millipore). Virus supernatant
was removed after 7 hr post-spin inoculation and cells were maintained in fresh growth medium for
48 hr before undergoing 3 mg/mL puromycin (Sigma-Aldrich) selection. Stable cell lines were gener-
ated after 8 days post-selection when cell stocks were frozen. The following shRNAs were used in
the experiments: SND1 KD1 (TRCN0000245143), SND1 KD2 (TRCN0000049656), METTL3 KD1
(TRCN0000289742), METTL3 KD2 (TRCN0000289812), FTO KD1 (TRCN0000246247), FTO KD2
(TRCN0000246250), YTHDF1 KD1 (TRCN0000062771), YTHDF1 KD2 (TRCN0000286871), YTHDF2
KD1 (TRCN0000254411), YTHDF2 KD2 (TRCN0000265510), YTHDF3 KD1 (TRCN0000365164) and
YTHDF3 KD2 (TRCN0000167772).
All shRNA plasmids were purchased from either Sigma-Aldrich or Dharmacon. Scramble shRNA
was a gift from Professor David Sabatini (Addgene plasmid # 1864).
Western blot analysis
Western blots were performed as previously described (Schumann et al., 2017). In brief, protein
samples were run on SDS-PAGE gels and transferred onto nitrocellulose membrane (GE healthcare)
via wet transfer. Membranes were blocked with TBS + 0.1% (v/v) Tween 20 (TBST) and 5% (w/v)
dried skimmed milk powder for 30 min, and then incubated for 1 hr with relevant primary and sec-
ondary antibodies diluted in 5% (w/v) milk TBST. Membranes were treated with either ECL Western
blotting substrate (Promega) or SuperSignal West Femto Maximum Sensitivity Luminol/Enhancer
solution (Thermo scientific) and exposed to Amersham hyperfilm ECL (GE Healthcare). Secondary
antibodies were horseradish peroxidase (HRP)-conjugated polyclonal goat anti-mouse (Dako) and
polyclonal goat anti-rabbit (Dako), both used at 1:5000 dilution.
Two-step quantitative reverse transcription PCR (qRT-PCR)
qRT-PCR was performed as previously described (Baquero-Pe´rez and Whitehouse, 2015). In brief,
total RNA from cells was extracted using TRIzol (Thermo Scientific) according to the supplier’s proto-
col. DNA-free DNA Removal Kit (Ambion) was used to remove any contaminating DNA from RNA
samples. Reverse transcription was performed with ProtoScript II (NEB), murine RNase inhibitor
(NEB), random hexamers (Bioline) and 1 mg of total RNA. Quantitative PCR (qPCR) reactions (20 ml)
included 1 X SensiMix SYBR green master mix (Bioline), 0.5 mM of each primer and 5 ml template
cDNA. Cycling was performed in a RotorGene Q 2plex machine (Qiagen). The cycling programme
was a 10 min initial preincubation at 95˚C, followed by 40 cycles of 95˚C for 15 s, 60˚C for 30 s and
72˚C for 20 s. After qPCR, a melting curve analysis was performed between 65˚C and 95˚C (with 0.2˚
C increments) to confirm amplification of a single product. To assess primer amplification efficiency
(AE), for each gene of interest a standard curve was constructed using a pool of cDNA derived from
unreactivated and reactivated cells. At least four different dilutions of pool cDNA were quantified to
generate a standard curve. The slope of the standard curve was used to calculate the AE of the pri-
mers using the formula: AE = (10 1/slope). For gene expression analysis all genes of interest were nor-
malised against the housekeeping gene GAPDH (DCT). A summary of all the primers used in this
study is provided in Supplementary file 3. Primers specific to METTL3 have previously been
described (Liu et al., 2014).
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RNA stability assays
TREx BCBL1-Rta cells were treated with 2.5 mg/ml of actinomycin D (Thermo Scientific) and samples
were collected at the desired time points. Total RNA was extracted using TRIzol (Thermo Scientific)
according to the supplier’s protocol. DNA-free DNA Removal Kit (Ambion) was used to remove any
contaminating DNA from RNA samples and qRT-PCR was carried out as described above. The gene
of interest was normalised against 18S rRNA, as this RNA, but not GAPDH, was stable after 6 hr of
actinomycin D treatment.
Chromatin immunoprecipitation (ChIP)
ChIP experiments were carried out as previously described (Baquero-Pe´rez and Whitehouse,
2015). Formaldehyde-crosslinked chromatin was prepared using the Pierce Chromatin Prep Module
(Thermo Scientific) following the manufacturer’s protocol with the following modified steps. 2  106
BCBL1 cells were used per immunoprecipitation and digested with 15 units of micrococcal nuclease
(MNase) per 100 ml of MNase Digestion buffer in a 37˚C water bath for 15 min. Nuclei were lysed for
30 min with lysis buffer two in addition to vortexing for 30 s every 5 min. Immunoprecipitations were
carried out using EZ-ChIP kit (Millipore) according to the supplier’s instructions. Immunoprecipita-
tions were done overnight at 4˚C and contained 50 ml of digested chromatin (2  106 cells), 450 ml of
ChIP dilution buffer and 2 mg of the antibody of interest. Primers for the KSHV promoter regions of
ORF50, Ori-Lyt, PAN RNA, ORF59 and K12 have been previously reported (Chen et al., 2009b;
Chen et al., 2012; Hughes et al., 2015). Primers for the cellular GAPDH promoter were supplied
with the EZ-ChIP kit. qPCR normalisation was performed similarly to RIP-qPCR experiments as
described above.
Proliferation (MTS) assay
Determination of the cellular metabolic activity was performed using a non-radioactive CellTiter 96
AQueous One Solution Cell Proliferation Assay (MTS) (Promega), according to the manufacturer’s
manual. 10,000 HEK-293 cells were seeded in quadruplicate in a flat 96-well culture plate (Corning).
After 26 hr inhibitor exposure, 20 ml of CellTiter 96 AQueous One Solution Reagent was added and
cells were incubated for 1 hr in a humidified incubator in 5% CO2 at 37˚C. Absorbance was measured
at 490 nm using a PowerWave XS2 (BioTek) plate reader.
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